col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


1116 Results       Page 1

 [1] 
Elsevier: The Lancet
  original article Date Title Authors   All Authors
1 [GO] 2024―Mar―22 Governance provisions in the WHO Pandemic Agreement draft Nina Schwalbe, Elliot Hannon, Lynda Gilby, Susanna Lehtimaki
2 [GO] 2024―Mar―22 A legal mapping of 48 WHO member states' inclusion of public health emergency of international concern, pandemic, and health emergency terminology within national emergency legislation in responding to health emergencies Clare Wenham, Liam Stout
3 [GO] 2024―Mar―19 Improving coherence of global research funding: Pandemic PACT Alice Norton, Louise Sigfrid, Emilia Antonio, Adrian Bucher, Duduzile Ndwandwe
4 [GO] 2024―Mar―11 Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign Marianne Shawe-Taylor, David Greenwood, Agnieszka Hobbs, Giulia Dowgier, Rebecca Penn, Theo Sanderson, et al. (+14)
5 [GO] 2024―Mar―11 Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 Austin E Schumacher, Hmwe Hmwe Kyu, Amirali Aali, Cristiana Abbafati, Jaffar Abbas, Rouzbeh Abbasgholizadeh, et al. (+1830)
6 [GO] 2024―Mar―07 mRNA-based therapeutics: looking beyond COVID-19 vaccines Hamideh Parhiz, Elena N Atochina-Vasserman, Drew Weissman
7 [GO] 2024―Feb―29 The Pandemic Treaty: shameful and unjust The Lancet
8 [GO] 2024―Feb―20 Candour, care, and COVID-19 Rageshri Dhairyawan
9 [GO] 2024―Feb―08 Draft of WHO Pandemic Agreement plays down primary prevention Thomas C Mettenleiter, Andrea S Winkler, Robyn Alders, John H Amuasi, Sania Ashraf, Daniel Becker, et al. (+24)
10 [GO] 2024―Jan―21 Undervaccination and severe COVID-19 outcomes: meta-analysis of national cohort studies in England, Northern Ireland, Scotland, and Wales Steven Kerr, Stuart Bedston, Genevieve Cezard, Alexia Sampri, Siobhan Murphy, Declan T Bradley, et al. (+21)
11 [GO] 2024―Jan―21 The Tokyo 2020 and Beijing 2022 Olympic Games held during the COVID-19 pandemic: planning, outcomes, and lessons learnt Brian McCloskey, Tomoya Saito, Satoshi Shimada, Chiaki Ikenoue, Tina Endericks, Lucia Mullen, et al. (+6)
12 [GO] 2024―Jan―15 Access to COVID-19 vaccination and COVID-19-related hospital admissions and mortality Martin C Gulliford, Claire J Steves
13 [GO] 2024―Jan―11 Interpreting COVID-19 data from China: a call for caution Zhi Qu
14 [GO] 2024―Jan―11 Interpreting COVID-19 data from China: a call for caution - Authors' reply Liang Wang, Quanyi Wang, George F Gao
15 [GO] 2024―Jan―11 Effects of the COVID-19 pandemic on NHS England waiting times for elective hospital care: a modelling study Syed Ahmar Shah, Chris Robertson, Aziz Sheikh
16 [GO] 2023―Dec―20 How modelling can better support public health policy making: the Lancet Commission on Strengthening the Use of Epidemiological Modelling of Emerging and Pandemic Infectious Diseases
17 [GO] 2023―Dec―15 Death and end of life in France after COVID-19 Philippe Charlier
18 [GO] 2023―Dec―15 Offline: Boris Johnson and COVID-19-more light than heat Richard Horton
19 [GO] 2023―Nov―24 Untangling the association between COVID-19 health literacy, trust in the pandemic response, and mental distress, during the COVID-19 pandemic in Ireland: a repeated cross-sectional study Julie Arnott, Maria Isabela Troya, Mary Joyce, Ali Khashan, Paul Corcoran, Zubair Kabir, et al. (+2)
20 [GO] 2023―Nov―24 Impact of long COVID-19 on work: a co-produced survey Nida Zia�n, Marija Pantelic, Margaret E O’Hara, Claire Hastie, Nisreen A Alwan
21 [GO] 2023―Nov―24 The role of the multiple Index of deprivation in predicting mental health outcomes after the COVID-19 pandemic in adolescents: a cross-sectional study Serendi Gulsen Hazir, Cían Ryan, Alison Moore, Charlie Lewis, Judith Lunn
22 [GO] 2023―Nov―24 Differences in the impact of the COVID-19 pandemic in the long-term trajectories of life satisfaction by sex in the UK: a prospective cohort study Darío Moreno-Agostino, Jayati Das-Munshi, George B Ploubidis
23 [GO] 2023―Nov―24 Changes in food and drink purchasing behaviour in England during the first 3 months of the COVID-19 pandemic: an interrupted time-series analysis Alexandra Kalbus, Laura Cornelsen, Andrea Ballatore, Steven Cummins
24 [GO] 2023―Nov―24 The Sussex COVID-19 Modelling Cell: the methods and successes of a collaboration between public health teams in local authorities, NHS hospital trusts, NHS commissioners, and universities James Van Yperen, Eduard Campillo-Funollet, Anjum Memon, Phil Allman, Jacqueline Clay, Matt Dorey, et al. (+3)
25 [GO] 2023―Nov―24 Mitigation of respiratory syncytial virus epidemics by RSVpreF vaccines after the COVID-19 pandemic in the UK: a modelling study Zhanwei Du, Lin Wang, Yuan Bai, Yao Pei, Peng Wu, Benjamin J Cowling
26 [GO] 2023―Nov―24 Impact of the COVID-19 pandemic on delayed care of cardiovascular diseases in Europe: a systematic review Yasmine Khan, Nick Verhaeghe, Brecht Devleesschauwer, Lisa Cavillot, Sylvie Gadeyne, Nele S Pauwels, et al. (+2)
27 [GO] 2023―Nov―24 Effect of trade unions on the mental health of UK workers before and during the COVID-19 pandemic: a longitudinal analysis using Understanding Society data Theocharis Kromydas, Evangelia Demou, Alastair H Leyland, Srinivasa Vittal Katikireddi, Jacques Wels
28 [GO] 2023―Nov―24 Exploring the experiences of junior doctors who were shielding during the COVID-19 pandemic: a qualitative study of semi-structured interviews Amy Martin, Susan Jamieson
29 [GO] 2023―Nov―09 Listening to the experiences of pandemic physicians Roopa Farooki
30 [GO] 2023―Nov―01 SARS-CoV-2 neutralising antibodies after a second BA.5 bivalent booster Qian Wang, Anthony Bowen, Jerren Ho, Richard M Zhang, Riccardo Valdez, Emily Stoneman, et al. (+3)
31 [GO] 2023―Oct―30 A crisis of trust in pandemic prevention, preparedness, and response Kolinda Grabar-Kitarović, Joy Phumaphi
32 [GO] 2023―Oct―12 Scientific advisory councils in the COVID-19 response Jean-François Delfraissy, Mary Horgan, Kåre Mølbak, Fernando Soria Simón, Tanja Stadler, Jaap van Dissel, et al. (+52)
33 [GO] 2023―Oct―11 The Lancet-PPATS Commission on Prevention of Viral Spillover: reducing the risk of pandemics through primary prevention Neil M Vora, Latiffah Hassan, Raina K Plowright, Richard Horton, Sonila Cook, Nigel Sizer, Aaron Bernstein
34 [GO] 2023―Oct―03 A gender-responsive Pandemic Accord is needed for a healthier, equitable future Shirin Heidari, Els Torreele, Ahmet Metin Gülmezoglu, Sharifah Sekalala, Naomi Burke-Shyne, Gabrielle Landry Chappuis
35 [GO] 2023―Sep―28 Striving to afford free health care in Greece during COVID-19 Christos Tsagkaris, Andreas S Papazoglou, Dimitrios V Moysidis, Stavros P Papadakos, Marios Papadakis
36 [GO] 2023―Sep―28 Cautionary notes on the COVID-19 re-infection study Zhi Qu
37 [GO] 2023―Sep―28 Community COVID-19 response in WHO's European region Leonardo Palumbo, Camila A Picchio, Catherine Smallwood, Cristiana Salvi, Gerald Rockenschaub
38 [GO] 2023―Sep―28 Arcturus (XBB.1.16) COVID-19 subvariant emergence in Indonesia Tungki Pratama Umar
39 [GO] 2023―Sep―28 Overcoming COVID-19 vaccine hesitancy hurdles Chengliang Yang, Linda Lapp, Scott J Tebbutt
40 [GO] 2023―Sep―28 COVID toes, newborn blue toes, and prepartum SARS-CoV-2 infection Ya Bin Zhou, Zi Gang Xu
41 [GO] 2023―Sep―28 COVID toes, newborn blue toes, and prepartum SARS-CoV-2 infection - Authors' reply Christoph Hochmayr, Ursula Kiechl-Kohlendorfer, Elke Griesmaier
42 [GO] 2023―Sep―28 Natural SARS-CoV-2 infection-induced immune protection against re-infection Claude Matuchansky
43 [GO] 2023―Sep―25 WHO pandemic accord: full adherence to the principle of sovereignty Ahmed Soliman, Kazuho Taguchi, Precious Matsoso, Roland Alexander Driece, Tovar da Silva Nunes, Viroj Tangcharoensathien
44 [GO] 2023―Sep―21 COVID-19 and Chinese nurses' mental health Hong Zhang
45 [GO] 2023―Sep―21 Bolsonaro's Ministry of Health's response to COVID-19 and other health challenges Raphael C M Parente, Marcelo Queiroga
46 [GO] 2023―Sep―21 Bolsonaro's Ministry of Health's response to COVID-19 and other health challenges - Authors' reply Adriano Massuda, Rafael Dall'Alba, Arthur Chioro, José Gomes Temporão, Márcia C Castro
47 [GO] 2023―Sep―15 What happened to the mpox pandemic? Tony Kirby
48 [GO] 2023―Sep―04 Increasing compliance with international pandemic law: international relations and new global health agreements Matthew M Kavanagh, Clare Wenham, Elize Massard da Fonseca, Lawrence R Helfer, Elvin Nyukuri, Allan Maleche, et al. (+3)
49 [GO] 2023―Aug―24 New Zealand's COVID-19 elimination strategy and mortality patterns Stacey Kung, Thomas Hills, Nethmi Kearns, Richard Beasley
50 [GO] 2023―Aug―17 Ending the HIV pandemic: preparing for the future The Lancet
51 [GO] 2023―Aug―07 Setbacks in the quest for universal health coverage in Mexico: polarised politics, policy upheaval, and pandemic disruption Felicia Marie Knaul, Hector Arreola-Ornelas, Michael Touchton, Tim McDonald, Merike Blofield, Leticia Avila Burgos, et al. (+11)
52 [GO] 2023―Jul―27 mRNA vaccines do not stop with COVID-19 Jin Zhou, Yu Zhang, Ke Mo, Herbert Newbert, Xicheng Song
53 [GO] 2023―Jul―27 COVID-19 and commerce complicate minimum unit pricing effects on health Nin-Chieh Hsu, Chia-Hao Hsu
54 [GO] 2023―Jul―27 COVID-19 and commerce complicate minimum unit pricing effects on health - Authors' reply Grant MA Wyper, Daniel F Mackay, Catriona Fraser, Jim Lewsey, Mark Robinson, Clare Beeston, Lucie Giles
55 [GO] 2023―Jul―27 Pandemics and the tourism industry: who is in control? Samuel d'Almeida, Thomas Althaus, Dominique Kerouedan
56 [GO] 2023―Jul―27 Pandemics move faster than funders
57 [GO] 2023―Jul―18 The big catch-up in immunisation coverage after the COVID-19 pandemic: progress and challenges to achieving equitable recovery Katherine L O'Brien, Ephrem Lemango
58 [GO] 2023―Jul―05 Addressing inequity: the world needs an ambitious Pandemic Accord Tovar da Silva Nunes, Ahmed Soliman, Kazuho Taguchi, Precious Matsoso, Roland Alexander Driece, Viroj Tangcharoensathien
59 [GO] 2023―Jun―29 Predicting COVID-19 infection risk in people who are immunocompromised by antibody testing Ratna Wijaya, Marina Johnson, Nicola Campbell, Beth Stuart, Adam Kelly, Nicole Tipler, et al. (+10)
60 [GO] 2023―Jun―29 The unfinished agenda of communicable diseases among children and adolescents before the COVID-19 pandemic, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019
61 [GO] 2023―Jun―23 Loneliness in the time of COVID-19: an alarming rise Shakshi Priya Giri, Anubhuti Dubey
62 [GO] 2023―Jun―19 Independent SARS-CoV-2 staff testing protected academic and health-care institutions in northwest London Chris Bailey, Theo Sanderson, Hermaleigh Townsley, Jacki Goldman, James R M Black, George Young, et al. (+47)
63 [GO] 2023―Jun―15 Backsliding on human rights and equity in the Pandemic Accord Rajat Khosla, David McCoy, Anna Marriot
64 [GO] 2023―Jun―12 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study Chaolin Huang, Lixue Huang, Yeming Wang, Xia Li, Lili Ren, Xiaoying Gu, et al. (+26)
65 [GO] 2023―Jun―10 Retraction and republication: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study The Lancet Editors
66 [GO] 2023―May―26 Learning from serosurveillance for SARS-CoV-2 to inform pandemic preparedness and response Sophie A Müller, Ambrose Agweyu, Olusola A Akanbi, Mary A Alex-Wele, Kokou N Alinon, Rahul K Arora, et al. (+36)
67 [GO] 2023―May―22 No time for complacency on COVID-19 in Europe Antoine Flahault, Alexandra Calmy, Dominique Costagliola, Oxana Drapkina, Isabella Eckerle, Heidi J Larson, et al. (+4)
68 [GO] 2023―May―19 Primary health care: a cornerstone of pandemic prevention, preparedness, response, and recovery Arush Lal, Nina Schwalbe
69 [GO] 2023―May―18 With the COVID-19 PHEIC over, what next? John Zarocostas
70 [GO] 2023―May―18 Tanzania's COVID-19 vaccination strategy: lessons, learning, and execution Sayoki Godfrey Mfinanga, Wangeci Gatei, Florian Tinuga, William Mngupe Patrick Mwengee, Zabulon Yoti, Ntuli Kapologwe, et al. (+3)
71 [GO] 2023―May―12 Reimagining health security and preventing future pandemics: the NUS-Lancet Pandemic Readiness, Implementation, Monitoring, and Evaluation Commission Helena Legido-Quigley, Helen Clark, Sania Nishtar, Richard Horton
72 [GO] 2023―May―11 The future of nursing: lessons from a pandemic The Lancet
73 [GO] 2023―May―09 The shared ethical framework to allocate scarce medical resources: a lesson from COVID-19 Ezekiel J Emanuel, Govind Persad
74 [GO] 2023―May―04 Eloise Todd: mobilising civil society for pandemic prevention Udani Samarasekera
75 [GO] 2023―Apr―27 Moving past the COVID-19 emergency in the USA The Lancet
76 [GO] 2023―Apr―27 COVID-19: forgetting a pandemic that is not over Jane Galvão
77 [GO] 2023―Apr―27 Moving towards a precision approach for prevention of severe COVID-19 - Authors' reply Utkarsh Agrawal, Chris Robertson, Aziz Sheikh
78 [GO] 2023―Apr―27 The Pandemic Fund-towards equitable financing for pandemics Nelson Aghogho Evaborhene
79 [GO] 2023―Apr―27 The importance of accountability in tackling future pandemics José Szapocznik, Guilherme Faviero, Akua S Dansua, Daniel G Bausch, Jorge Saavedra
80 [GO] 2023―Apr―27 Moving towards a precision approach for prevention of severe COVID-19 Westyn Branch-Elliman, Paul A Monach
81 [GO] 2023―Apr―21 Offline: The UK COVID-19 Inquiry-be patient, but don’t wait Richard Horton
82 [GO] 2023―Apr―21 State-to-state differences in US COVID-19 outcomes: searching for explanations Nicole Lurie, Joshua M Sharfstein
83 [GO] 2023―Apr―21 Lessons learned from COVID-19 to stop future pandemics Thomas Cueni
84 [GO] 2023―Apr―18 Indigenous health-care sovereignty defines resilience to the COVID-19 pandemic Andrey N Petrov, Dalee Sambo Dorough, Sweta Tiwari, Mark Welford, Nikolay Golosov, Michele Devlin, et al. (+3)
85 [GO] 2023―Apr―14 Differential diagnosis of blue toes in a newborn baby: might have been maternal infection with COVID-19? Christoph Hochmayr, Michael Auckenthaler, Franz-Martin Fink, Ursula Kiechl-Kohlendorfer, Elke Griesmaier
86 [GO] 2023―Apr―14 Calls for transparency in pandemic accord talks Talha Burki
87 [GO] 2023―Apr―13 Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, Joshua Abbas, Kasim Abbas, Mustafa Abbas, et al. (+8101)
88 [GO] 2023―Apr―13 Higher-dose dexamethasone for patients with COVID-19 and hypoxaemia? Anders Perner, Balasubramanian Venkatesh
89 [GO] 2023―Apr―05 A WHO pandemic instrument: substantive provisions required to address global shortcomings Roland Alexander Driece, Precious Matsoso, Tovar da Silva Nunes, Ahmed Soliman, Kazuho Taguchi, Viroj Tangcharoensathien
90 [GO] 2023―Mar―31 Retraction-Chinese medical personnel after the COVID-19 pandemic The Editors of The Lancet
91 [GO] 2023―Mar―23 Assessing COVID-19 pandemic policies and behaviours and their economic and educational trade-offs across US states from Jan 1, 2020, to July 31, 2022: an observational analysis Thomas J Bollyky, Emma Castro, Aleksandr Y Aravkin, Kayleigh Bhangdia, Jeremy Dalos, Erin N Hulland, et al. (+52)
92 [GO] 2023―Mar―23 Chinese medical personnel after the COVID-19 pandemic Liyang Sun, Hangdong Jia, Tian Yang
93 [GO] 2023―Mar―09 International cooperation to end the COVID-19 pandemic Zhi Qu
94 [GO] 2023―Mar―02 Confronting the evolution and expansion of anti-vaccine activism in the USA in the COVID-19 era Richard M Carpiano, Timothy Callaghan, Renee DiResta, Noel T Brewer, Chelsea Clinton, Alison P Galvani, et al. (+15)
95 [GO] 2023―Feb―23 China's COVID-19 reopening measures-warriors and weapons Shujie Huang, Zhen Gao, Sichao Wang
96 [GO] 2023―Feb―16 COVID-19 infection, reinfection, and the transition to endemicity Cheryl Cohen, Juliet Pulliam
97 [GO] 2023―Feb―16 Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis Caroline Stein, Hasan Nassereldine, Reed J D Sorensen, Joanne O Amlag, Catherine Bisignano, Sam Byrne, et al. (+20)
98 [GO] 2023―Feb―09 So far, no novel SARS-CoV-2 variants from Beijing-and hopefully better scientific cooperation going forward Wolfgang Preiser, Tongai Maponga
99 [GO] 2023―Feb―09 Characterisation of SARS-CoV-2 variants in Beijing during 2022: an epidemiological and phylogenetic analysis Yang Pan, Liang Wang, Zhaomin Feng, Hui Xu, Fu Li, Ying Shen, et al. (+4)
100 [GO] 2023―Feb―09 Conflicting COVID-19 excess mortality estimates Jonas Schöley, Ariel Karlinsky, Dmitry Kobak, Charles Tallack
101 [GO] 2023―Feb―09 Conflicting COVID-19 excess mortality estimates Alberto Donzelli
102 [GO] 2023―Feb―09 Conflicting COVID-19 excess mortality estimates Peter Bager, Jens Nielsen, Samir Bhatt, Lise Birk Nielsen, Tyra Grove Krause, Lasse Skafte Vestergaard
103 [GO] 2023―Feb―09 Conflicting COVID-19 excess mortality estimates Matshidiso Moeti, Lindiwe Makubalo, Abdou Salam Gueye, Thierno Balde, Humphrey Karamagi, Gordon Awandare, et al. (+4)
104 [GO] 2023―Feb―09 Conflicting COVID-19 excess mortality estimates Desmond O'Neill
105 [GO] 2023―Feb―09 Conflicting COVID-19 excess mortality estimates - Authors' reply Simon I Hay, Christopher J L Murray
106 [GO] 2023―Jan―31 Independent monitoring for the pandemic accord: a non-negotiable provision Layth Hanbali, Susanna Lehtimaki, Elliot Hannon, Christine McNab, Nina Schwalbe
107 [GO] 2023―Jan―18 COVID-19 vaccination is effective at preventing severe illness and complications during pregnancy Sascha Ellington, Tara C Jatlaoui
108 [GO] 2023―Jan―13 COVID-19 and other pandemics require a coherent response strategy Michael G Baker, David Durrheim, Li Yang Hsu, Nick Wilson
109 [GO] 2023―Jan―12 The COVID-19 pandemic in 2023: far from over The Lancet
110 [GO] 2022―Dec―22 Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial Christopher C Butler, F D Richard Hobbs, Oghenekome A Gbinigie, Najib M Rahman, Gail Hayward, Duncan B Richards, et al. (+129)
111 [GO] 2022―Dec―22 Uptake of monoclonal antibodies and antiviral therapies for COVID-19 in Scotland Holly Tibble, Tanja Mueller, Euan Proud, Elliott Hall, Amanj Kurdi, Chris Robertson, et al. (+3)
112 [GO] 2022―Dec―22 PANORAMIC: important insights into molnupiravir use in COVID-19 Michael R Kidd, Paul M Kelly
113 [GO] 2022―Dec―15 Louis Pasteur, COVID-19, and the social challenges of epidemics Tamara Giles-Vernick, Phaik Yeong Cheah, Gustavo Matta, Nisia Trindade Lima
114 [GO] 2022―Dec―14 Community pandemic response: the importance of action led by communities and the public sector Winnie Byanyima, Karl Lauterbach, Matthew M Kavanagh
115 [GO] 2022―Dec―02 Integrated respiratory surveillance after the COVID-19 pandemic William Elson, Maria Zambon, Simon de Lusignan
116 [GO] 2022―Nov―25 Bayesian reconstruction of household transmissions to infer the serial interval of COVID-19 by variants of concern: analysis from a prospective community cohort study (Virus Watch) Cyril Geismar, Vincent Nguyen, Ellen Fragaszy, Madhumita Shrotri, Annalan M D Navaratnam, Sarah Beale, et al. (+10)
117 [GO] 2022―Nov―25 COVID-19 and the role of Voluntary, Community, and Social Enterprises in northern England in responding to the needs of marginalised communities: a qualitative focus group study Stephanie Scott, Victoria J McGowan, Josephine M Wildman, Elaine Bidmead, Jane Hartley, Claire Mathews, et al. (+4)
118 [GO] 2022―Nov―25 Expression of concern: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study The Lancet Editors
119 [GO] 2022―Nov―25 The effect of indoor soundscape on sexual wellbeing during the COVID-19 lockdown in London: a thematic analysis of remote workers' experiences Simone Torresin, Eleanor Ratcliffe, Francesco Aletta, Rossano Albatici, Francesco Babich, Tin Oberman, Jian Kang
120 [GO] 2022―Nov―25 How did living in temporary accommodation during the COVID-19 pandemic affect children younger than 5 years' access to health care and health outcomes? A qualitative study of key professionals in a socially and ethnically diverse and deprived area of London Diana Margot Rosenthal, Michelle Heys, Antoinette Schoenthaler, Andrew Hayward, Marcella Ucci, Celine Lewis
121 [GO] 2022―Nov―25 Changes in online food access during the COVID-19 pandemic and associations with deprivation: a longitudinal analysis Matthew Keeble, Jean Adams, Thomas Burgoine
122 [GO] 2022―Nov―25 Engagement of individuals aged 14-25 years with a digital mental health service during the COVID-19 pandemic in the UK: a cohort study of service usage data Aynsley Bernard, Louisa Salhi, Santiago de Ossorno Garcia, Ann John, Marcos del Pozo-Baños
123 [GO] 2022―Nov―25 Experience of homelessness during the COVID-19 pandemic in Tower Hamlets, London: a health needs assessment Sam Tweed
124 [GO] 2022―Nov―25 Effect of the COVID-19 pandemic on incidence of long-term conditions in Welsh residents: a population linkage study Cathy Qi, Timothy Osborne, Rowena Bailey, Joe Hollinghurst, Ashley Akbari, Alison Cooper, et al. (+5)
125 [GO] 2022―Nov―25 The impact of the COVID-19 pandemic on people experiencing homelessness: a qualitative interview study in the UK Jo Dawes, Tom May, Daisy Fancourt, Alexandra Burton
126 [GO] 2022―Nov―25 Mental health of the nursing and midwifery workforce in Wales during the COVID-19 pandemic: a cross-sectional analysis Benjamin J Gray, Richard G Kyle, Aimée Challenger, Alisha R Davies
127 [GO] 2022―Nov―25 Shifting priorities and employment choices among workers in Wales during the COVID-19 pandemic: a longitudinal analysis Melda Lois Griffiths, Benjamin J Gray, Richard G Kyle, Alisha R Davies
128 [GO] 2022―Nov―25 Impact of the temporary suspension of the Bowel Screening Wales programme on inequalities during the COVID-19 pandemic: a retrospective register-based study Diana Bright, Jiao Song, Sharon Hillier, Dyfed W Huws, Giles Greene, Karen Hodgson, et al. (+4)
129 [GO] 2022―Nov―25 How did female survivors of abuse use the arts to support their mental health and wellbeing during the COVID-19 pandemic? A qualitative exploration of their views Alison R McKinlay, Lorna Collins, Daisy Fancourt, Alexandra Burton
130 [GO] 2022―Nov―25 COVID-19 vaccination uptake for half a million non-EU migrants and refugees in England: a linked retrospective population-based cohort study Rachel Burns, Ines Campos-Matos, Katie Harron, Robert W Aldridge
131 [GO] 2022―Nov―25 Implementing behavioural science informed letter interventions to increase COVID-19 vaccination uptake in uncontactable London residents: a difference-in-difference study in London, UK Sarah W Huf, Lena Woldmann, Roberto Fernandez Crespo, Kate Grailey, Bahram Hassanpourfard, Matthew Chisambi, et al. (+4)
132 [GO] 2022―Nov―25 The UK's Free School Meals policy during the pandemic: a thematic content analysis of policy documents and debates Jennie C Parnham, Eszter P Vamos, Sarah McKevitt, Anthony A Laverty
133 [GO] 2022―Nov―17 Human rights and the COVID-19 pandemic: a retrospective and prospective analysis Lawrence O Gostin, Eric A Friedman, Sara Hossain, Joia Mukherjee, Saman Zia-Zarifi, Chelsea Clinton, et al. (+4)
134 [GO] 2022―Nov―17 Offline: COVID-19-the lessons that science forgot Richard Horton
135 [GO] 2022―Nov―17 US CDC begins agency-wide changes after pandemic failures Susan Jaffe
136 [GO] 2022―Nov―10 WHO Living Guidelines on antivirals for COVID-19 are evidence-based Andrew Owen, Janet Victoria Diaz, Gordon Guyatt, François Lamontagne, Miriam Stegemann, Per Olav Vandvik, Thomas Agoritsas
137 [GO] 2022―Oct―27 COVID-19 and other adult vaccines can drive global disease prevention David B Agus, Aurélia Nguyen, Amadou Alpha Sall, John Bell
138 [GO] 2022―Oct―27 Challenges and opportunities for educating health professionals after the COVID-19 pandemic Julio Frenk, Lincoln C Chen, Latha Chandran, Elizabeth O H Groff, Roderick King, Afaf Meleis, Harvey V Fineberg
139 [GO] 2022―Oct―27 Pandemic solidarity across national borders saved lives Mitali Das, Kieren Keke
140 [GO] 2022―Oct―26 The legacy of the COVID-19 pandemic for childhood vaccination in the USA Douglas J Opel, Noel T Brewer, Alison M Buttenheim, Timothy Callaghan, Richard M Carpiano, Chelsea Clinton, et al. (+15)
141 [GO] 2022―Oct―24 After 2 years of the COVID-19 pandemic, translating One Health into action is urgent Thierry Lefrançois, Denis Malvy, Laetitia Atlani-Duault, Daniel Benamouzig, Pierre-Louis Druais, Yazdan Yazdanpanah, et al. (+2)
142 [GO] 2022―Oct―14 Prioritisation of COVID-19 boosters in the omicron era Stephanie A Irving, Maria E Sundaram
143 [GO] 2022―Oct―14 Resistance to COVID-19 controls in an anthropologist's home town Mary T Bassett
144 [GO] 2022―Oct―14 Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales Utkarsh Agrawal, Stuart Bedston, Colin McCowan, Jason Oke, Lynsey Patterson, Chris Robertson, et al. (+21)
145 [GO] 2022―Oct―14 Reconsidering the COVID-19 vaccine strategy in West and Central Africa Philippe Msellati, Khoudia Sow, Alice Desclaux, Gilles Cottrell, Mamadou Diallo, Jean-Yves Le Hesran, et al. (+4)
146 [GO] 2022―Oct―07 Real-world effectiveness of oral antivirals for COVID-19 Charles Burdet, Florence Ader
147 [GO] 2022―Oct―07 A reinvigorated multilateralism in health: lessons and innovations from the COVID-19 pandemic Julio Frenk, Tore Godal, Octavio Gómez-Dantés, Jonas Gahr Store
148 [GO] 2022―Oct―07 Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: an observational study Carlos K H Wong, Ivan C H Au, Kristy T K Lau, Eric H Y Lau, Benjamin J Cowling, Gabriel M Leung
149 [GO] 2022―Oct―06 WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessed Mary Y Wu, Edward J Carr, Ruth Harvey, Harriet V Mears, Svend Kjaer, Hermaleigh Townsley, et al. (+13)
150 [GO] 2022―Sep―22 Characterising adults in Scotland who are not vaccinated against COVID-19 Safraj Shahul Hameed, Elliott Hall, Zoe Grange, Christopher Sullivan, Sharon Kennedy, Lewis D Ritchie, et al. (+8)
151 [GO] 2022―Sep―14 The Lancet Commission on lessons for the future from the COVID-19 pandemic Jeffrey D Sachs, Salim S Abdool Karim, Lara Aknin, Joseph Allen, Kirsten Brosbøl, Francesca Colombo, et al. (+34)
152 [GO] 2022―Sep―14 COVID-19: the case for prosociality The Lancet
153 [GO] 2022―Sep―08 Misclassification bias in estimating clinical severity of SARS-CoV-2 variants Christina Yek, Sarah Warner, Alex Mancera, Sameer S Kadri
154 [GO] 2022―Sep―08 Misclassification bias in estimating clinical severity of SARS-CoV-2 variants - Authors' reply Tommy Nyberg, Neil M Ferguson, Joshua Blake, Wes Hinsley, Samir Bhatt, Daniela De Angelis, et al. (+2)
155 [GO] 2022―Sep―01 Protecting older people: a high priority during the COVID-19 pandemic Yifei Zhang, Yufan Wang, Guang Ning, Ping He, Weiqing Wang
156 [GO] 2022―Sep―01 New centre for pandemic therapeutics Jacqui Thornton
157 [GO] 2022―Aug―26 Trust made the difference for democracies in COVID-19 Thomas J Bollyky, Olivia Angelino, Simon Wigley, Joseph L Dieleman
158 [GO] 2022―Aug―26 Forgetting pandemics may be hazardous to your health Howard Markel
159 [GO] 2022―Aug―04 COVID-19 and microbiome diversity in sub-Saharan Africa Wim Van Damme, Richard Wamai, Yibeltal Assefa, Laurens Liesenborghs, Dieudonné Mumba
160 [GO] 2022―Aug―04 COVID-19 and microbiome diversity in sub-Saharan Africa - Author's reply Reed J D Sorensen
161 [GO] 2022―Aug―04 Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study Aranka V Ballering, Sander K R van Zon, Tim C olde Hartman, Judith G M Rosmalen
162 [GO] 2022―Aug―04 Long COVID: which symptoms can be attributed to SARS-CoV-2 infection? Christopher E Brightling, Rachael A Evans
163 [GO] 2022―Aug―04 Global pandemic perspectives: public health, mental health, and lessons for the future Matshidiso Moeti, George F Gao, Helen Herrman
164 [GO] 2022―Jul―28 Violence against health workers rises during COVID-19 Jacqui Thornton
165 [GO] 2022―Jul―28 Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Obbina Abani, Ali Abbas, Fatima Abbas, Joshua Abbas, Kasim Abbas, Mustafa Abbas, et al. (+7936)
166 [GO] 2022―Jul―28 Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing mortality Puja Mehta, Boghuma K Titanji
167 [GO] 2022―Jul―18 The UK COVID-19 Inquiry must examine the foundations of pandemic decision making Tom Lawton, Nisreen A Alwan
168 [GO] 2022―Jul―14 Preparing for uncertainty: endemic paediatric viral illnesses after COVID-19 pandemic disruption Kevin Messacar, Rachel E Baker, Sang Woo Park, Hai Nguyen-Tran, Jessica R Cataldi, Bryan Grenfell
169 [GO] 2022―Jul―11 Perilous two-tier COVID-19 global vaccine roll-out David N Durrheim
170 [GO] 2022―Jul―08 Effectiveness of vaccination mandates in improving uptake of COVID-19 vaccines in the USA Michelle M Mello, Douglas J Opel, Regina M Benjamin, Timothy Callaghan, Renee DiResta, Jad A Elharake, et al. (+14)
171 [GO] 2022―Jul―06 Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa Ameena Goga, Linda-Gail Bekker, Nigel Garrett, Tarylee Reddy, Nonhlanhla Yende-Zuma, Lara Fairall, et al. (+7)
172 [GO] 2022―Jul―01 Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy: a retrospective analysis of January-April, 2022 Chiara Sacco, Martina Del Manso, Alberto Mateo-Urdiales, Maria Cristina Rota, Daniele Petrone, Flavia Riccardo, et al. (+11)
173 [GO] 2022―Jul―01 COVID-19 vaccination for children aged 5-11 years Shamez N Ladhani
174 [GO] 2022―Jul―01 Shifting gender barriers in immunisation in the COVID-19 pandemic response and beyond Tiffany Nassiri-Ansari, Phionah Atuhebwe, Akosua Sika Ayisi, Sarah Goulding, Mira Johri, Pascale Allotey, Nina Schwalbe
175 [GO] 2022―Jul―01 Monkeypox genomic surveillance will challenge lessons learned from SARS-CoV-2 Florian Pfaff, Donata Hoffmann, Martin Beer
176 [GO] 2022―Jun―29 A new paradigm is needed for financing the pandemic fund Simon Reid-Henry, Jon Lidén, Christoph Benn, Diah Saminarsih, Olivia Herlinda, María Fernanda Bustos Venegas
177 [GO] 2022―Jun―23 COVID-19 in North Korea Talha Burki
178 [GO] 2022―Jun―16 Memorialising COVID-19 Danielle Ofri
179 [GO] 2022―Jun―16 Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2 Michela Antonelli, Joan Capdevila Pujol, Tim D Spector, Sebastien Ourselin, Claire J Steves
180 [GO] 2022―Jun―10 COVID-19 mRNA vaccination and myocarditis or pericarditis Anders Husby, Lars Køber
181 [GO] 2022―Jun―10 Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases Hui-Lee Wong, Mao Hu, Cindy Ke Zhou, Patricia C Lloyd, Kandace L Amend, Daniel C Beachler, et al. (+18)
182 [GO] 2022―Jun―10 Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial Grace Li, Federica Cappuccini, Natalie G Marchevsky, Parvinder K Aley, Robert Aley, Rachel Anslow, et al. (+65)
183 [GO] 2022―Jun―10 Increasing children's global access to COVID-19 vaccines Manish Patel, Minal Patel
184 [GO] 2022―May―30 Pandemic preparedness means policy makers need to work with social scientists Martyn Pickersgill, Lucinda Manda-Taylor, Natalia Niño-Machado
185 [GO] 2022―May―25 COVID-19 boosters and building trust among UK minority ethnic communities Laura B Nellums, Asam Latif, Kennedy Nkhoma, Stephen Timmons, Manish Pareek, Salma Almidani, Basharat Hussain
186 [GO] 2022―May―19 Where is the next SARS-CoV-2 variant of concern? John J Dennehy, Ravindra K Gupta, William P Hanage, Marc C Johnson, Thomas P Peacock
187 [GO] 2022―May―19 Offline: How to fix pandemic preparedness Richard Horton
188 [GO] 2022―May―18 Transforming or tinkering: the world remains unprepared for the next pandemic threat Helen Clark, Mauricio Cardenas, Mark Dybul, Michel Kazatchkine, Joanne Liu, David Miliband, et al. (+10)
189 [GO] 2022―May―12 Raj Panjabi: bringing a global outlook to the US pandemic response Susan Jaffe
190 [GO] 2022―May―06 Counting the global COVID-19 dead Prabhat Jha, Patrick E Brown, Rashid Ansumana
191 [GO] 2022―May―06 Shanghai's life-saving efforts against the current omicron wave of the COVID-19 pandemic Xinxin Zhang, Wenhong Zhang, Saijuan Chen
192 [GO] 2022―May―05 COVID-19 and inter-generational solidarity Peter Lloyd Sherlock
193 [GO] 2022―May―05 COVID-19: the next phase and beyond The Lancet
194 [GO] 2022―May―05 A global view of the pandemic: the good, bad, and ugly Philip Ball
195 [GO] 2022―May―02 Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
196 [GO] 2022―Apr―28 Africa CDC warns COVID-19 vaccine production could cease Paul Adepoju
197 [GO] 2022―Apr―28 Finding hope in two pandemics Ofole Mgbako
198 [GO] 2022―Apr―25 Responding to the humanitarian crisis of the war in Ukraine with lessons from COVID-19 David Archard, Alena Buyx, Jean-François Delfraissy
199 [GO] 2022―Apr―21 Transforming the UK's diagnostics agenda after COVID-19 Dimitris K Grammatopoulos, Lawrence Young, Neil R Anderson
200 [GO] 2022―Apr―14 Cracks in the foundation: how COVID-19 showed our failures Mary T Bassett
201 [GO] 2022―Apr―14 Advancing accurate metrics for future pandemic preparedness Francine Ntoumi, Alimuddin Zumla
202 [GO] 2022―Apr―11 What comes next in the COVID-19 pandemic? Dale Fisher, Sameera Suri, Gail Carson
203 [GO] 2022―Apr―08 How to interpret the total number of SARS-CoV-2 infections Kayoko Shioda, Ben Lopman
204 [GO] 2022―Apr―08 Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis Ryan M Barber, Reed J D Sorensen, David M Pigott, Catherine Bisignano, Austin Carter, Joanne O Amlag, et al. (+66)
205 [GO] 2022―Apr―07 SARS-CoV-2 nucleic acid testing is China's key pillar of COVID-19 containment Xiaoxu Han, Jinming Li, Yu Chen, Yan Li, Yingchun Xu, Binwu Ying, Hong Shang
206 [GO] 2022―Apr―07 COVID-19 vaccination and HIV-1 acquisition Denis Y Logunov, David M Livermore, David A Ornelles, Wibke Bayer, Ernesto Marques, Cecil Czerkinsky, et al. (+2)
207 [GO] 2022―Apr―07 COVID-19 vaccination and HIV-1 acquisition - Authors’ reply Susan P Buchbinder, M Juliana McElrath, Carl Dieffenbach, Lawrence Corey
208 [GO] 2022―Apr―07 Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study Cristina Menni, Ana M Valdes, Lorenzo Polidori, Michela Antonelli, Satya Penamakuri, Ana Nogal, et al. (+18)
209 [GO] 2022―Mar―31 DNA vaccines join the fight against COVID-19 Anna K Blakney, Linda-Gail Bekker
210 [GO] 2022―Mar―31 Mixed response to COVID-19 intellectual property waiver John Zarocostas
211 [GO] 2022―Mar―31 Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India Akash Khobragade, Suresh Bhate, Vijendra Ramaiah, Shrikant Deshpande, Krishna Giri, Himanshu Phophle, et al. (+9)
212 [GO] 2022―Mar―25 Booster vaccines for COVID-19 vaccine breakthrough cases? Douglas F Nixon, Robert E Schwartz, Lishomwa C Ndhlovu
213 [GO] 2022―Mar―25 Booster vaccines for COVID-19 vaccine breakthrough cases? - Authors' reply Philip R Krause, Helen Rees, J Peter Figueroa, Soumya Swaminathan, Ana Maria Henao Restrepo
214 [GO] 2022―Mar―25 Strengthening public mental health during and after the acute phase of the COVID-19 pandemic Lola Kola, Manasi Kumar, Brandon A Kohrt, Tobi Fatodun, Bisola A Olayemi, Adeyinka O Adefolarin
215 [GO] 2022―Mar―25 SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses Maaike C Swets, Clark D Russell, Ewen M Harrison, Annemarie B Docherty, Nazir Lone, Michelle Girvan, et al. (+6)
216 [GO] 2022―Mar―25 Host-targeting oral antiviral drugs to prevent pandemics Raymond A Dwek, John I Bell, Marc Feldmann, Nicole Zitzmann
217 [GO] 2022―Mar―22 Ritonavir and COVID-19: pragmatic guidance is important Laura Waters, Fiona Marra, Anton Pozniak, James Cockburn, Marta Boffito
218 [GO] 2022―Mar―16 Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study Tommy Nyberg, Neil M Ferguson, Sophie G Nash, Harriet H Webster, Seth Flaxman, Nick Andrews, et al. (+46)
219 [GO] 2022―Mar―15 Effectiveness of rAd26-rAd5, ChAdOx1 nCoV-19, and BBIBP-CorV vaccines for risk of infection with SARS-CoV-2 and death due to COVID-19 in people older than 60 years in Argentina: a test-negative, case-control, and retrospective longitudinal study Analía Rearte, Juan Manuel Castelli, Ramiro Rearte, Nora Fuentes, Velen Pennini, Martina Pesce, et al. (+11)
220 [GO] 2022―Mar―15 Evaluating COVID-19 vaccines in the real world Edward J Mills, Gilmar Reis
221 [GO] 2022―Mar―10 Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21 Haidong Wang, Katherine R Paulson, Spencer A Pease, Stefanie Watson, Haley Comfort, Peng Zheng, et al. (+90)
222 [GO] 2022―Mar―10 Transmission of SARS-CoV-2 delta variant (AY.127) from pet hamsters to humans, leading to onward human-to-human transmission: a case study Hui-Ling Yen, Thomas H C Sit, Christopher J Brackman, Shirley S Y Chuk, Haogao Gu, Karina W S Tam, et al. (+19)
223 [GO] 2022―Mar―10 Spreading of SARS-CoV-2 from hamsters to humans Bart L Haagmans, Marion P G Koopmans
224 [GO] 2022―Mar―03 Quantifying the effects of the COVID-19 pandemic on gender equality on health, social, and economic indicators: a comprehensive review of data from March, 2020, to September, 2021 Luisa S Flor, Joseph Friedman, Cory N Spencer, John Cagney, Alejandra Arrieta, Molly E Herbert, et al. (+16)
225 [GO] 2022―Mar―03 Brazil's COVID-19 guidelines: political hijack of public health Luis C L Correia, Cristina Sette, Marisa Santos, Carlos A S Magliano, Fotini S Toscas
226 [GO] 2022―Mar―02 Gender equality and COVID-19: act now before it is too late Rosemary Morgan, Denise Nacif Pimenta, Sabina Rashid
227 [GO] 2022―Mar―02 Travel measures in the SARS-CoV-2 variant era need clear objectives Adam J Kucharski, Mark Jit, James G Logan, Matthew Cotten, Samuel Clifford, Billy J Quilty, et al. (+4)
228 [GO] 2022―Feb―24 Understanding of COVID-19 from infection-fatality ratio Xiaoying Gu, Bin Cao
229 [GO] 2022―Feb―24 Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis
230 [GO] 2022―Feb―24 The global COVID-19 treatment divide Ann Danaiya Usher
231 [GO] 2022―Feb―24 Waning effectiveness of COVID-19 vaccines Hiam Chemaitelly, Laith J Abu-Raddad
232 [GO] 2022―Feb―23 Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression Daniel R Feikin, Melissa M Higdon, Laith J Abu-Raddad, Nick Andrews, Rafael Araos, Yair Goldberg, et al. (+8)
233 [GO] 2022―Feb―23 Waning of COVID-19 vaccine effectiveness: individual and public health risk Vanessa Piechotta, Thomas Harder
234 [GO] 2022―Feb―18 Decoupling of omicron variant infections and severe COVID-19 Shabir A Madhi, Chikwe Ihekweazu, Helen Rees, Andrew J Pollard
235 [GO] 2022―Feb―18 COVID-19 booster doses in pregnancy and global vaccine equity Erkan Kalafat, Laura A Magee, Peter von Dadelszen, Paul Heath, Asma Khalil
236 [GO] 2022―Feb―16 Children, intersectionality, and COVID-19 Katy Dineen, Bengt Autzen, Nisreen A Alwan
237 [GO] 2022―Feb―10 Offline: Complacency threatens progress against COVID-19 Richard Horton
238 [GO] 2022―Feb―10 The vaccinated propor-tion of people with COVID-19 needs context Sam Egger, Garry Egger
239 [GO] 2022―Feb―10 Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, Mustafa Abbas, Sadia Abbasi, Hakam Abbass, et al. (+6297)
240 [GO] 2022―Feb―10 Another piece in the COVID-19 treatment puzzle Cristina Mussini, Alessandro Cozzi-Lepri
241 [GO] 2022―Feb―05 Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden Peter Nordström, Marcel Ballin, Anna Nordström
242 [GO] 2022―Feb―03 Depression and anxiety during COVID-19 - Authors' reply Damian F Santomauro, Harvey A Whiteford, Alize J Ferrari
243 [GO] 2022―Feb―03 Depression and anxiety during COVID-19 Michael Daly, Eric Robinson
244 [GO] 2022―Feb―03 COVID-19 in Europe: new challenges for addressing vaccine hesitancy Emilie Karafillakis, Pierre Van Damme, Greet Hendrickx, Heidi J Larson
245 [GO] 2022―Feb―03 WHO concerned over COVID-19 health-care waste John Zarocostas
246 [GO] 2022―Feb―03 Ayoade Alakija: advancing equity in the COVID-19 response Udani Samarasekera
247 [GO] 2022―Feb―03 Transmission of SARS-CoV-2: still up in the air Alison Lopez, Jocelyn Srigley
248 [GO] 2022―Feb―03 Transmission of SARS-CoV-2: still up in the air - Authors' reply Trisha Greenhalgh, Jose L Jimenez, Kimberly A Prather, Zeynep Tufeki, David Fisman, Robert Schooley
249 [GO] 2022―Feb―03 Xenophobia, prejudice, and blame in pandemic times Alexandre I R White
250 [GO] 2022―Feb―02 Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021 Thomas J Bollyky, Erin N Hulland, Ryan M Barber, James K Collins, Samantha Kiernan, Mark Moses, et al. (+79)
251 [GO] 2022―Jan―28 Polish Government COVID-19 advisors resign Ed Holt
252 [GO] 2022―Jan―28 High-dose immunoglobulins from convalescent donors for patients hospitalised with COVID-19 Cynthia So-Osman, Sarah J Valk
253 [GO] 2022―Jan―28 Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial Mark N. Polizzotto, Jacqueline Nordwall, Abdel G. Babiker, Andrew Phillips, David M. Vock, Nnakelu Eriobu, et al. (+82)
254 [GO] 2022―Jan―28 Offline: Sex and power during a pandemic Richard Horton
255 [GO] 2022―Jan―28 Urgent care: disability, pandemic, and the value of a life Rachel Adams
256 [GO] 2022―Jan―25 Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer Annika Fendler, Scott T C Shepherd, Lewis Au, Mary Wu, Ruth Harvey, Andreas M Schmitt, et al. (+55)
257 [GO] 2022―Jan―21 Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study Sue Ann Costa Clemens, Lily Weckx, Ralf Clemens, Ana Verena Almeida Mendes, Alessandra Ramos Souza, Mariana B V Silveira, et al. (+40)
258 [GO] 2022―Jan―20 Recognising Italy's mistakes in the public health response to COVID-19 Chiara Alfieri, Marc Egrot, Alice Desclaux, Kelley Sams
259 [GO] 2022―Jan―20 Offline: COVID-19 as culture war Richard Horton
260 [GO] 2022―Jan―20 The COVID-19 response in Hong Kong Tong B Tang
261 [GO] 2022―Jan―20 Omicron neutralising antibodies after COVID-19 vaccination in haemodialysis patients Edward J Carr, Mary Wu, Ruth Harvey, Roseanne E Billany, Emma C Wall, Gavin Kelly, et al. (+11)
262 [GO] 2022―Jan―20 Trimeric S protein COVID-19 vaccine needs to find its place Timo Vesikari
263 [GO] 2022―Jan―20 Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study Nicole Wolter, Waasila Jassat, Sibongile Walaza, Richard Welch, Harry Moultrie, Michelle Groome, et al. (+22)
264 [GO] 2022―Jan―20 The overlooked pandemic of antimicrobial resistance Ramanan Laxminarayan
265 [GO] 2022―Jan―20 COVID-19 will continue but the end of the pandemic is near Christopher J L Murray
266 [GO] 2022―Jan―20 Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial Lulu Bravo, Igor Smolenov, Htay Htay Han, Ping Li, Romana Hosain, Frank Rockhold, et al. (+41)
267 [GO] 2022―Jan―18 Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose Constanze Kuhlmann, Carla Konstanze Mayer, Mathilda Claassen, Tongai Maponga, Wendy A Burgers, Roanne Keeton, et al. (+5)
268 [GO] 2022―Jan―13 Disrupted care in Papua New Guinea: the harms of COVID-19 Chris McCall
269 [GO] 2022―Jan―13 Ground glass opacities are not always COVID-19: a case of acute eosinophilic pneumonitis caused by daptomycin Rajalakshmi Valaiyapathi, Meng-San Wu, Alastair McGregor
270 [GO] 2021―Dec―31 COVID-19 ARDS: getting ventilation right - Authors' reply Ryan P Barbaro, Graeme MacLaren, Justyna Swol, Arthur S Slutsky, Daniel Brodie
271 [GO] 2021―Dec―31 COVID-19 ARDS: getting ventilation right Xosé L Pérez-Fernández, Joan Sabater-Riera, MariPaz Fuset-Cabanes
272 [GO] 2021―Dec―31 Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management Joseph Heskin, Scott J C Pallett, Nabeela Mughal, Gary W Davies, Luke S P Moore, Michael Rayment, Rachael Jones
273 [GO] 2021―Dec―24 Mandatory COVID-19 vaccination and human rights Jeff King, Octávio Luiz Motta Ferraz, Andrew Jones
274 [GO] 2021―Dec―24 Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial Scott A Halperin, Lingyun Ye, Donna MacKinnon-Cameron, Bruce Smith, Pedro E Cahn, Guillermo M Ruiz-Palacios, et al. (+42)
275 [GO] 2021―Dec―24 Efficacy of an adenovirus type 5 vectored SARS-CoV-2 vaccine Richard B Kennedy
276 [GO] 2021―Dec―22 LGBTQ youth mental health during COVID-19: unmet needs in public health and policy Cameron K Ormiston, Faustine Williams
277 [GO] 2021―Dec―20 Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil Srinivasa Vittal Katikireddi, Thiago Cerqueira-Silva, Eleftheria Vasileiou, Chris Robertson, Sarah Amele, Jiafeng Pan, et al. (+18)
278 [GO] 2021―Dec―20 Diagnostics for COVID-19: moving from pandemic response to control Rosanna W Peeling, David L Heymann, Yik-Ying Teo, Patricia J Garcia
279 [GO] 2021―Dec―20 Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum Wanwisa Dejnirattisai, Robert H Shaw, Piyada Supasa, Chang Liu, Arabella SV Stuart, Andrew J Pollard, et al. (+8)
280 [GO] 2021―Dec―20 Managing waning vaccine protection against SARS-CoV-2 variants Kathy Leung, Joseph T Wu
281 [GO] 2021―Dec―16 Projecting COVID-19 disruption to elective surgery COVIDSurg Collaborative
282 [GO] 2021―Dec―16 COVID-19 vaccine strategies must focus on severe disease and global equity Peter B McIntyre, Rakesh Aggarwal, Ilesh Jani, Jaleela Jawad, Sonali Kochhar, Noni MacDonald, et al. (+9)
283 [GO] 2021―Dec―16 COVID-19: where do we go from here? The Lancet
284 [GO] 2021―Dec―15 Anticoagulation in COVID-19 Charlotte A Bradbury, Zoe McQuilten
285 [GO] 2021―Dec―15 Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial Eduardo Ramacciotti, Leandro Barile Agati, Daniela Calderaro, Valéria Cristina Resende Aguiar, Alex C Spyropoulos, Caroline Candida Carvalho de Oliveira, et al. (+38)
286 [GO] 2021―Dec―11 Governing the Access to COVID-19 Tools Accelerator: towards greater participation, transparency, and accountability Suerie Moon, Jana Armstrong, Brian Hutler, Ross Upshur, Rachel Katz, Caesar Atuire, et al. (+12)
287 [GO] 2021―Dec―09 High-dose budesonide for early COVID-19 Brian Lipworth, Rory Chan, Rasads Misirovs
288 [GO] 2021―Dec―09 High-dose budesonide for early COVID-19 Ivan Berezowski, Jigar Patel, Mariame Shaw, Ali Pourmand
289 [GO] 2021―Dec―09 High-dose budesonide for early COVID-19 - Authors' reply F D Richard Hobbs, Ly-Mee Yu, Benjamin R Saville, Mona Bafadhel, Christopher C Butler
290 [GO] 2021―Dec―08 Preparing for future pandemics in the Eastern Mediterranean region Wasiq Khan, Abdinasir Abubakar, Richard J Brennan, Farida Al Hosani, Thoraya Obaid, Anders Nordstrom, Peter Friberg
291 [GO] 2021―Dec―06 Mixing mRNA, adenoviral, and spike-adjuvant vaccines for protection against COVID-19 Christopher D Richardson
292 [GO] 2021―Dec―06 Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial Arabella S V Stuart, Robert H Shaw, Xinxue Liu, Melanie Greenland, Parvinder K Aley, Nick J Andrews, et al. (+37)
293 [GO] 2021―Dec―03 Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic Salim S Abdool Karim, Quarraisha Abdool Karim
294 [GO] 2021―Dec―02 Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial Alasdair P S Munro, Leila Janani, Victoria Cornelius, Parvinder K Aley, Gavin Babbage, David Baxter, et al. (+301)
295 [GO] 2021―Nov―26 Evaluation of the impact of tiered restrictions introduced in England during October and December, 2020, on COVID-19 cases: a synthetic control study Xingna Zhang, Gwilym Owen, Mark Green, Iain Buchan, Ben Barr
296 [GO] 2021―Nov―26 COVID-19 and prepandemic all-cause inequalities in disability-adjusted life-years due to multiple deprivation: a Scottish Burden of Disease study Grant M A Wyper, Eilidh Fletcher, Ian Grant, Oliver Harding, Maria Teresa de Haro Moro, Diane L Stockton, Gerry McCartney
297 [GO] 2021―Nov―26 “It's been up and down”-perspectives on living through COVID-19 for individuals who experience homelessness: a qualitative study Emma A Adams, Jeff Parker, Tony Jablonski, Joanne Kennedy, Desmond Hunter, Fiona Tasker, et al. (+9)
298 [GO] 2021―Nov―26 SARS-CoV-2 testing, infections, and hospital admissions with COVID-19 in children and young people in Scotland: a birth cohort study Graziella Favarato, Linda Wijlaars, Tom Clemens, Steve Cunningham, Bianca De Stavola, Chris Dibben, et al. (+7)
299 [GO] 2021―Nov―26 The severity of COVID-19 infection in patients with anorexia nervosa: an observational study Michael J Taylor, Uju Okereke, Robert Wilson, Anthony Winston
300 [GO] 2021―Nov―26 An exploration of the uptake of asymptomatic COVID-19 lateral flow testing in Birmingham, UK: cross-sectional survey and qualitative analysis Jonathan Mathers, Christopher Poyner, Dean Thompson, Gavin Rudge, Ruth Pritchett
301 [GO] 2021―Nov―26 Resilience of elective cancer surgery systems during COVID-19 lockdowns: an international, multicentre, prospective cohort study
302 [GO] 2021―Nov―26 Attitudes towards COVID-19 mitigation measures implemented at St Mark's Bowel Cancer Screening Centre: a cross-sectional analysis of survey data from an ethnically diverse region in London Andrew Prentice, Ghalial Kayal, Sarah Marshall, Christian von Wagner, Robert S Kerrison
303 [GO] 2021―Nov―26 Measuring the impact of COVID-19 on sexual and reproductive health in the UK: web-panel surveys with qualitative follow-up Nigel Field, Emily Dema, Andrew J Copas, Soazig Clifton, Anne Conolly, Margaret Blake, et al. (+8)
304 [GO] 2021―Nov―26 Individuals with lived experience of homelessness and their COVID-19 outcomes in Wales: a data linkage study Jiao Song, Chris Moreno-Stokoe, Charlotte Grey, Alisha R Davies
305 [GO] 2021―Nov―26 Health protocol compliance integrated monitoring system to inform public health actions during the COVID-19 pandemic in Indonesia Dewi Nur Aisyah, Thifal Kiasatina, Gayatri I Gusti, Wiku Adisasmito, Logan Manikam, Zisis Kozlakidis
306 [GO] 2021―Nov―26 Population birth outcomes and experiences of expectant mothers during the COVID-19 pandemic in Wales: a mixed methods study Hope Jones, Mike Seaborne, Laura Cowley, David Odd, Shantini Paranjothy, Ashley Akbari, Sinead Brophy
307 [GO] 2021―Nov―26 Community-led action in response to the COVID-19 pandemic in Wales: a national, cross-sectional survey Charlotte N B Grey, Lucia Homolova, Alisha Davies
308 [GO] 2021―Nov―26 Impact of the COVID-19 pandemic on health-care usage and mental health of clinically extremely vulnerable individuals in Wales: a population-scale data linkage study Alisha Davies, Jiao Song, Ashley Akbari, Laura Bentley, Bethan Carter, Lynsey Cross, et al. (+6)
309 [GO] 2021―Nov―26 Impact of the COVID-19 pandemic on psychotropic medication uptake in Northern Ireland: a population-wide trend analysis Lisa Kent, Dermot O'Reilly, Aideen Maguire
310 [GO] 2021―Nov―26 Effects of the COVID-19 pandemic on the mental health of shielded children and children living in shielded households in Wales: a data linkage study Laura Cowley, Jiao Song, Alisha Davies
311 [GO] 2021―Nov―26 Estimating the direct and indirect risks of becoming food insecure during the COVID-19 pandemic: a cross-sectional analysis using UK cohort data Susanna Mills, Viviana Albani, Heather Brown
312 [GO] 2021―Nov―26 Understanding risk and protective factors to UK railway workers' mental wellbeing during the COVID-19 pandemic: a cross-sectional survey Nicola Cogan, Megan McGibbon, Amy Gardener, Liza Morton
313 [GO] 2021―Nov―26 The importance of adaptive coping, peer support, psychological input, team resilience, and supportive management among fire and rescue service workers in maintaining wellbeing throughout the COVID-19 pandemic: a cross-sectional survey Nicola Cogan, Amy MacDonald
314 [GO] 2021―Nov―26 Variations in the incidence of common mental disorder symptoms in the general population throughout the COVID-19 pandemic: a longitudinal cohort study Rob Saunders, Joshua Eusty Jonathan Buckman, Peter Fonagy, Stephen Pilling, Feifei Bu, Daisy Fancourt
315 [GO] 2021―Nov―26 The effect of school and peer connectedness on adolescent mental health outcomes during the COVID-19 pandemic: a longitudinal panel survey Emily Widnall, Lizzy Winstone, Ruth Plackett, Emma Adams, Claire Haworth, Becky Mars, Judi Kidger
316 [GO] 2021―Nov―26 Exploring the role of people providing informal support to survivors of domestic abuse during the COVID-19 pandemic: a qualitative study Alison Gregory, Emma Williamson
317 [GO] 2021―Nov―26 Community-led support in South Wales in response to the COVID-19 pandemic: a qualitative study with a systems-lens approach Lucia Homolova, Charlotte N B Grey, Alisha Davies
318 [GO] 2021―Nov―26 Reduced ability to engage in social and physical activity and mental health of older adults during the COVID-19 pandemic: longitudinal analysis from the Canadian Longitudinal Study on Aging Theodore D Cosco, Andrew Wister, Indira Riadi, Lucy Kervin, John Best, Parminder Raina
319 [GO] 2021―Nov―26 Scientific advice and COVID-19 policy making in the UK: an oral history study Paul Atkinson, Hayley Mableson, Sally Sheard
320 [GO] 2021―Nov―26 COVID-19 recovery from the community perspective in Middlesbrough: a coproduction cross-sectional study Andrew Divers, Catherine Parker, Parisa Diba, Clifford Johnson, Dorothy Newbury-Birch
321 [GO] 2021―Nov―26 Placing health equity at the heart of the COVID-19 recovery: data analysis from the first Welsh Health Equity Status Report initiative James Allen, Andrew Cotter-Roberts, Anna Stielke, Rajendra Kadel, Benjamin Bainham, Kathryn Ashton, et al. (+2)
322 [GO] 2021―Nov―26 Increased COVID-19 related mortality rate for patients with rare diseases: a retrospective cohort study with data from Genomics England Huayu Zhang, Johan Thygesen, Honghan Wu
323 [GO] 2021―Nov―26 Design and implementation of a university-based COVID-19 testing programme: an observational study Claire Blackmore, Gareth W Hall, Rebecca C Allsopp, Anna L Hansell, Caroline M Cowley, Ruth C Barber, et al. (+5)
324 [GO] 2021―Nov―26 Challenges of self-isolation among contacts of cases of COVID-19: a national telephone survey in Wales Kate R Isherwood, Richard G Kyle, Benjamin J Gray, Alisha R Davies
325 [GO] 2021―Nov―26 Community-academic partnerships addressing local health inequalities during COVID-19: a qualitative evaluation Meerat Kaur, Bethany Golding, Arti Maini, Sonia Kumar
326 [GO] 2021―Nov―26 A pilot study of PCR community mass testing for COVID-19: who attends and who tests positive? Kate Levin, Beatrix von Wissmann
327 [GO] 2021―Nov―25 COVID-19 and myocardial infarction Daniel Caldeira, Fausto J Pinto
328 [GO] 2021―Nov―25 COVID-19 and myocardial infarction - Authors' reply Ioannis Katsoularis, Osvaldo Fonseca-Rodríguez, Paddy Farrington, Krister Lindmark, Anne-Marie Fors Connolly
329 [GO] 2021―Nov―25 A reproductive justice response to HIV/AIDS and COVID-19 Jallicia Jolly
330 [GO] 2021―Nov―25 Beyond COVID-19: scaling up and sustaining mobile health in Africa - Authors' reply N Hélène Sawadogo, Hamidou Sanou, Jeremy A Greene, Vincent Duclos
331 [GO] 2021―Nov―25 Beyond COVID-19: scaling up and sustaining mobile health in Africa Yap Boum
332 [GO] 2021―Nov―25 Countries prepare for pandemic treaty decision John Zarocostas
333 [GO] 2021―Nov―18 Long-term effects on survivors with COVID-19 Chengliang Yang, Hedi Zhao, Scott J Tebbutt
334 [GO] 2021―Nov―18 Long-term effects on survivors with COVID-19 Yan-Jie Zhao, Wei Bai, Zhaohui Su, Chee H Ng, Yu-Tao Xiang
335 [GO] 2021―Nov―18 Long-term effects on survivors with COVID-19 - Authors' reply Lixue Huang, Xiaoying Gu, Bin Cao
336 [GO] 2021―Nov―18 Legal challenges threaten Biden's COVID-19 vaccine rule Susan Jaffe
337 [GO] 2021―Nov―18 COVID-19: stigmatising the unvaccinated is not justified Günter Kampf
338 [GO] 2021―Nov―17 Studying the coagulopathy of COVID-19 Alex C Spyropoulos, Marc P Bonaca
339 [GO] 2021―Nov―17 Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, Mustafa Abbas, Sadia Abbasi, Hakam Abbass, et al. (+6209)
340 [GO] 2021―Nov―15 Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA Saad B Omer, Regina M Benjamin, Noel T Brewer, Alison M Buttenheim, Timothy Callaghan, Arthur Caplan, et al. (+16)
341 [GO] 2021―Nov―11 Inactivated SARS-CoV-2 vaccine (BBV152)-induced protection against symptomatic COVID-19 Jing-Xin Li, Feng-Cai Zhu
342 [GO] 2021―Nov―11 Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial Rajeka Lazarus, Sarah Baos, Heike Cappel-Porter, Andrew Carson-Stevens, Madeleine Clout, Lucy Culliford, et al. (+178)
343 [GO] 2021―Nov―11 Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial Raches Ella, Siddarth Reddy, William Blackwelder, Varsha Potdar, Pragya Yadav, Vamshi Sarangi, et al. (+23)
344 [GO] 2021―Nov―11 Just how common is TTS after a second dose of the ChAdOx1 nCov-19 vaccine? Sue Pavord, Marie Scully, Will Lester, Mike Makris, Beverley J Hunt
345 [GO] 2021―Nov―11 Just how common is TTS after a second dose of the ChAdOx1 nCov-19 vaccine? - Authors’ reply Prakash Bhuyan, Jennie Medin, Hugo Gomes da Silva, Madhavi Yadavalli, Magnus Nord
346 [GO] 2021―Nov―08 How an outbreak became a pandemic: a chronological analysis of crucial junctures and international obligations in the early months of the COVID-19 pandemic Sudhvir Singh, Christine McNab, Rose McKeon Olson, Nellie Bristol, Cody Nolan, Elin Bergstrøm, et al. (+11)
347 [GO] 2021―Nov―04 Health experts welcome Brazil COVID-19 inquiry findings Lise Alves
348 [GO] 2021―Nov―03 Estimating the early impact of the US COVID-19 vaccination programme on COVID-19 cases, emergency department visits, hospital admissions, and deaths among adults aged 65 years and older: an ecological analysis of national surveillance data Lucy A McNamara, Ryan E Wiegand, Rachel M Burke, Andrea J Sharma, Michael Sheppard, Jennifer Adjemian, et al. (+16)
349 [GO] 2021―Nov―03 The value of vaccine programme impact monitoring during the COVID-19 pandemic Justin R Ortiz, Kathleen M Neuzil
350 [GO] 2021―Oct―29 Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study Noam Barda, Noa Dagan, Cyrille Cohen, Miguel A Hernán, Marc Lipsitch, Isaac S Kohane, et al. (+2)
351 [GO] 2021―Oct―28 Characteristics and risk of COVID-19-related death in fully vaccinated people in Scotland Zoe Grange, Audrey Buelo, Christopher Sullivan, Emily Moore, Utkarsh Agrawal, Khaled Boukhari, et al. (+6)
352 [GO] 2021―Oct―28 Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study Raphael Sonabend, Lilith K Whittles, Natsuko Imai, Pablo N Perez-Guzman, Edward S Knock, Thomas Rawson, et al. (+11)
353 [GO] 2021―Oct―28 Unclear conclusions on SARS-CoV-2 elimination versus mitigation Christian Gold
354 [GO] 2021―Oct―28 Unclear conclusions on SARS-CoV-2 elimination versus mitigation - Authors' reply Miquel Oliu-Barton, Bary S R Pradelski, Philippe Aghion, Patrick Artus, Ilona Kickbusch, Jeffrey V Lazarus, Samantha Vanderslott
355 [GO] 2021―Oct―28 Nowcasting towards sustainable SARS-CoV-2 endemicity Gabriel M Leung
356 [GO] 2021―Oct―22 COVID-19 and the rebiologisation of racial difference Wingel Xue, Alexandre White
357 [GO] 2021―Oct―22 Fertility rates and birth outcomes after ChAdOx1 nCoV-19 (AZD1222) vaccination Kushalinii Hillson, Sue Costa Clemens, Shabir A Madhi, Merryn Voysey, Andrew J Pollard, Angela M Minassian
358 [GO] 2021―Oct―15 Developing COVID-19 vaccine policy in increments Michael S Saag
359 [GO] 2021―Oct―09 Depression and anxiety disorders during the COVID-19 pandemic: knowns and unknowns Maxime Taquet, Emily A Holmes, Paul J Harrison
360 [GO] 2021―Oct―09 Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic Damian F Santomauro, Ana M Mantilla Herrera, Jamileh Shadid, Peng Zheng, Charlie Ashbaugh, David M Pigott, et al. (+61)
361 [GO] 2021―Oct―08 Age-adjusted D-dimer cutoffs to guide anticoagulation in COVID-19 - Authors' reply Renato D Lopes, Pedro Gabriel Melo de Barros e Silva, Remo H M Furtado, John H Alexander, Otavio Berwanger
362 [GO] 2021―Oct―08 Age-adjusted D-dimer cutoffs to guide anticoagulation in COVID-19 Marco Zuin, Gianluca Rigatelli, Giovanni Zuliani, Loris Roncon
363 [GO] 2021―Oct―08 The path to global equity in mental health care in the context of COVID-19 Lola Kola, Brandon A Kohrt, Bibhav Acharya, Byamah B Mutamba, Christian Kieling, Manasi Kumar, et al. (+3)
364 [GO] 2021―Oct―07 Can COVID-19 help accelerate and transform the diagnostics agenda? Sabine Kleinert, Richard Horton
365 [GO] 2021―Oct―05 Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study Sara Y Tartof, Jeff M Slezak, Heidi Fischer, Vennis Hong, Bradley K Ackerson, Omesh N Ranasinghe, et al. (+9)
366 [GO] 2021―Oct―05 Navigating from SARS-CoV-2 elimination to endemicity in Australia, Hong Kong, New Zealand, and Singapore Chuan De Foo, Karen A Grépin, Alex R Cook, Li Yang Hsu, Michael Bartos, Sudhvir Singh, et al. (+4)
367 [GO] 2021―Oct―05 Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipients Maria Prendecki, Tina Thomson, Candice L Clarke, Paul Martin, Sarah Gleeson, Rute Cardoso De Aguiar, et al. (+11)
368 [GO] 2021―Sep―30 Extracorporeal membrane oxygenation for COVID-19: evolving outcomes from the international Extracorporeal Life Support Organization Registry Ryan P Barbaro, Graeme MacLaren, Philip S Boonstra, Alain Combes, Cara Agerstrand, Gail Annich, et al. (+10)
369 [GO] 2021―Sep―30 COVID-19 research in LMICs Ivan Sisa, Marco Fornasini, Enrique Teran
370 [GO] 2021―Sep―30 COVID-19 research in LMICs - Authors' reply Irene Torres, Barbara Profeta, Cristiani Vieira Machado, Osvaldo Artaza, Daniel Lopez-Cevallos, JaHyun Kang
371 [GO] 2021―Sep―29 World Heart Day 2021: COVID-19, digital health, and tackling cardiovascular disease Fausto J Pinto, Daniel Piñeiro, Amitava Banerjee, Pablo Perel, Borjana Pervan, Jean-Luc Eiselé
372 [GO] 2021―Sep―29 ECMO in COVID-19: do not blame the tool Alain Vuylsteke
373 [GO] 2021―Sep―24 Functioning of the International Health Regulations during the COVID-19 pandemic Preben Aavitsland, Ximena Aguilera, Seif Salem Al-Abri, Vincent Amani, Carmen C Aramburu, Thouraya A Attia, et al. (+13)
374 [GO] 2021―Sep―23 Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050 Angela E Micah, Ian E Cogswell, Brandon Cunningham, Satoshi Ezoe, Anton C Harle, Emilie R Maddison, et al. (+407)
375 [GO] 2021―Sep―23 COVID-19: learning as an interdependent world The Lancet
376 [GO] 2021―Sep―22 The long-term impact of COVID-19 on development assistance for health is still uncertain Osondu Ogbuoji, Wenhui Mao, Genevieve Aryeetey
377 [GO] 2021―Sep―17 An appeal for an objective, open, and transparent scientific debate about the origin of SARS-CoV-2 Jacques van Helden, Colin D Butler, Guillaume Achaz, Bruno Canard, Didier Casane, Jean-Michel Claverie, et al. (+10)
378 [GO] 2021―Sep―17 An appeal for an objective, open, and transparent scientific debate about the origin of SARS-CoV-2 - Authors' reply Gerald T Keusch, Sai Kit Lam, John S Mackenzie, Linda Saif, Michael Turner
379 [GO] 2021―Sep―17 SARS-CoV-2's origin should be investigated worldwide for pandemic prevention Zhiqiang Wu, Qi Jin, Guizhen Wu, Jian Lu, Mingkun Li, Deyin Guo, et al. (+9)
380 [GO] 2021―Sep―14 Considerations in boosting COVID-19 vaccine immune responses Philip R Krause, Thomas R Fleming, Richard Peto, Ira M Longini, J Peter Figueroa, Jonathan A C Sterne, et al. (+12)
381 [GO] 2021―Sep―14 Daily testing for contacts of individuals with SARS-CoV-2 infection and attendance and SARS-CoV-2 transmission in English secondary schools and colleges: an open-label, cluster-randomised trial Bernadette C Young, David W Eyre, Saroj Kendrick, Chris White, Sylvester Smith, George Beveridge, et al. (+25)
382 [GO] 2021―Sep―10 A new strategy for health and sustainable development in the light of the COVID-19 pandemic Mario Monti, Aleksandra Torbica, Elias Mossialos, Martin McKee
383 [GO] 2021―Sep―02 The long road ahead for COVID-19 vaccination in Africa Sara Jerving
384 [GO] 2021―Sep―02 The race to make a COVID-19 vaccine Sarah Boseley
385 [GO] 2021―Sep―01 Global youth advocating for COVID-19 vaccines for all Neema Kaseje, David Walcott
386 [GO] 2021―Sep―01 Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002) Amy Flaxman, Natalie G Marchevsky, Daniel Jenkin, Jeremy Aboagye, Parvinder K Aley, Brian Angus, et al. (+181)
387 [GO] 2021―Sep―01 Longer intervals and extra doses of ChAdOx1 nCoV-19 vaccine Elizabeth T Rogawski McQuade, Alexander Breskin
388 [GO] 2021―Aug―26 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study Lixue Huang, Qun Yao, Xiaoying Gu, Qiongya Wang, Lili Ren, Yeming Wang, et al. (+19)
389 [GO] 2021―Aug―24 Institutional imperatives for the advancement of women in medicine and science through the COVID-19 pandemic Arghavan Salles, Reshma Jagsi
390 [GO] 2021―Aug―17 SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination Georg MN Behrens, Anne Cossmann, Metodi V Stankov, Inga Nehlmeier, Amy Kempf, Markus Hoffmann, Stefan Pöhlmann
391 [GO] 2021―Aug―13 Tackling Latin America's COVID-19 emergency requires greater solidarity Carissa F Etienne
392 [GO] 2021―Aug―13 Hospital-acquired SARS-CoV-2 infection in the UK's first COVID-19 pandemic wave Jonathan M Read, Chris A Green, Ewen M Harrison, Annemarie B Docherty, Sebastian Funk, Janet Harrison, et al. (+8)
393 [GO] 2021―Aug―13 Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients Edward J Carr, Mary Wu, Ruth Harvey, Emma C Wall, Gavin Kelly, Saira Hussain, et al. (+78)
394 [GO] 2021―Aug―12 SARS-CoV-2 vaccination in pregnancy: a unique opportunity for equity Erkan Kalafat, Laura A Magee, Peter von Dadelszen, Pat O’Brien, Asma Khalil
395 [GO] 2021―Aug―10 The use of inhaled corticosteroids in early-stage COVID-19 Dee Mangin, Michelle Howard
396 [GO] 2021―Aug―10 Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial Ly-Mee Yu, Mona Bafadhel, Jienchi Dorward, Gail Hayward, Benjamin R Saville, Oghenekome Gbinigie, et al. (+46)
397 [GO] 2021―Aug―10 Serial intervals in SARS-CoV-2 B.1.617.2 variant cases Rachael Pung, Tze Minn Mak, Adam J Kucharski, Vernon J Lee
398 [GO] 2021―Aug―09 Towards a European strategy to address the COVID-19 pandemic Viola Priesemann, Rudi Balling, Simon Bauer, Philippe Beutels, André Calero Valdez, Sarah Cuschieri, et al. (+22)
399 [GO] 2021―Aug―06 Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study Richard J Perry, Arina Tamborska, Bhagteshwar Singh, Brian Craven, Richard Marigold, Peter Arthur-Farraj, et al. (+70)
400 [GO] 2021―Aug―06 Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial Xinxue Liu, Robert H Shaw, Arabella S V Stuart, Melanie Greenland, Parvinder K Aley, Nick J Andrews, et al. (+82)
401 [GO] 2021―Aug―06 Optimising SARS-CoV-2 vaccination schedules Cristobal Belda-Iniesta
402 [GO] 2021―Aug―05 COVID-19, online shaming, and health-care professionals Luna Dolezal, Arthur Rose, Fred Cooper
403 [GO] 2021―Aug―05 Critically ill COVID-19 patients in Africa: it is time for quality registry data Luigi Pisani, Wangari Waweru-Siika, Cornelius Sendagire, Abi Beane, Rashan Haniffa
404 [GO] 2021―Aug―05 Critically ill COVID-19 patients in Africa: it is time for quality registry data - Authors' reply Bruce M Biccard, David Thomson, Malcolm Miller, Elliott H Taylor, P Dean Gopalan
405 [GO] 2021―Aug―04 Mucormycosis after COVID-19 in a patient with diabetes Khushboo Chauhan, Deepak Soni, Deepayan Sarkar, Tadepalli Karuna, Bhavana Sharma, Sarman Singh, Samendra Karkhur
406 [GO] 2021―Jul―30 COVID-19 vaccines for children in LMICs: another equity issue Beate Kampmann, Uduak Okomo
407 [GO] 2021―Jul―29 Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study Ioannis Katsoularis, Osvaldo Fonseca-Rodríguez, Paddy Farrington, Krister Lindmark, Anne-Marie Fors Connolly
408 [GO] 2021―Jul―29 What is the association of COVID-19 with heart attacks and strokes? Marion Mafham, Colin Baigent
409 [GO] 2021―Jul―29 Ethnic disparities in COVID-19: increased risk of infection or severe disease? Daniel Pan, Christopher A Martin, Joshua Nazareth, Clareece R Nevill, Jatinder S Minhas, Pip Divall, et al. (+5)
410 [GO] 2021―Jul―29 Ethnic disparities in COVID-19: increased risk of infection or severe disease? - Authors' reply Rohini Mathur, Christopher T Rentsch, Caroline E Morton, Rosalind M Eggo, Krishnan Bhaskaran, Laurie Tomlinsonn, et al. (+2)
411 [GO] 2021―Jul―29 Should global financing be the main priority for pandemic preparedness? Carel IJsselmuiden, Francine Ntoumi, James V Lavery, Jaime Montoya, Salim Abdool Karim, Kirsty Kaiser
412 [GO] 2021―Jul―29 Should global financing be the main priority for pandemic preparedness? - Authors' reply Nicole Lurie, Gerald T Keusch, Victor J Dzau
413 [GO] 2021―Jul―22 Tocilizumab in COVID-19 therapy: who benefits, and how? Avidan U Neumann, Mehmet Goekkaya, Karim Dorgham, Claudia Traidl-Hoffmann, Guy Gorochov
414 [GO] 2021―Jul―22 Tocilizumab in COVID-19 therapy: who benefits, and how? Chengliang Yang, Hedi Zhao
415 [GO] 2021―Jul―22 Tocilizumab in COVID-19 therapy: who benefits, and how? - Authors' reply Peter Horby, Natalie Staplin, Richard Haynes, Martin Landray
416 [GO] 2021―Jul―21 Answering the call to support youth orphaned by COVID-19 Rachel A Kentor, Amanda L Thompson
417 [GO] 2021―Jul―21 Scaling up urban infrastructure for physical activity in the COVID-19 pandemic and beyond Alejandra Jáuregui, Estelle Victoria Lambert, Jenna Panter, Clover Moore, Deborah Salvo
418 [GO] 2021―Jul―21 Global minimum estimates of children affected by COVID-19-associated orphanhood and deaths of caregivers: a modelling study Susan D Hillis, H Juliette T Unwin, Yu Chen, Lucie Cluver, Lorraine Sherr, Philip S Goldman, et al. (+10)
419 [GO] 2021―Jul―20 Will the COVID-19 crisis catalyse universal health reforms? Lucinda Hiam, Robert Yates
420 [GO] 2021―Jul―20 COVID-19: the turning point for gender equality Senait Fisseha, Gita Sen, Tedros Adhanom Ghebreyesus, Winnie Byanyima, Debora Diniz, Henrietta H Fore, et al. (+11)
421 [GO] 2021―Jul―17 In-hospital complications associated with COVID-19 Xiaoying Gu, Bin Cao
422 [GO] 2021―Jul―17 COVID-19 in Africa: a lesson in solidarity The Lancet
423 [GO] 2021―Jul―17 Disruptions to childhood immunisation due to the COVID-19 pandemic Kaja Abbas, Vittal Mogasale
424 [GO] 2021―Jul―17 Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study Kate Causey, Nancy Fullman, Reed J D Sorensen, Natalie C Galles, Peng Zheng, Aleksandr Aravkin, et al. (+12)
425 [GO] 2021―Jul―17 Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study Thomas M Drake, Aya M Riad, Cameron J Fairfield, Conor Egan, Stephen R Knight, Riinu Pius, et al. (+397)
426 [GO] 2021―Jul―17 COVID-19: counting migrants in Sally Hargreaves, Sally E Hayward, Teymur Noori, Martin McKee, Bernadette Kumar
427 [GO] 2021―Jul―08 COVID-19 in Latin America-emergency and opportunity The Lancet
428 [GO] 2021―Jul―08 Addressing the real trajectory of COVID-19 in the Eastern Mediterranean region Khuloud Alsaba
429 [GO] 2021―Jul―08 Addressing the real trajectory of COVID-19 in the Eastern Mediterranean region - Authors' reply Pierre Nabeth, Mahmoud Hassan, Keyrellous Adib, Abdinasir Abubakar, Richard Brennan
430 [GO] 2021―Jul―08 WHO COVID-19 therapeutic guidelines Bram Rochwerg, Thomas Agoritsas, Janet Diaz, Lisa Askie
431 [GO] 2021―Jul―08 WHO COVID-19 therapeutic guidelines - Authors' reply Nicholas J White, Nathalie Strub-Wourgaft, Abul Faiz, Philippe J Guerin
432 [GO] 2021―Jul―08 Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey Mine Durusu Tanriover, Hamdi Levent Doğanay, Murat Akova, Hatice Rahmet Güner, Alpay Azap, Sıla Akhan, et al. (+70)
433 [GO] 2021―Jul―06 7-1-7: an organising principle, target, and accountability metric to make the world safer from pandemics Thomas R Frieden, Christopher T Lee, Aaron F Bochner, Marine Buissonnière, Amanda McClelland
434 [GO] 2021―Jul―05 Science, not speculation, is essential to determine how SARS-CoV-2 reached humans Charles H Calisher, Dennis Carroll, Rita Colwell, Ronald B Corley, Peter Daszak, Christian Drosten, et al. (+18)
435 [GO] 2021―Jul―01 Widespread implementation of a low-cost telehealth service in the delivery of antenatal care during the COVID-19 pandemic: an interrupted time-series analysis Kirsten R Palmer, Michael Tanner, Miranda Davies-Tuck, Andrea Rindt, Kerrie Papacostas, Michelle L Giles, et al. (+9)
436 [GO] 2021―Jul―01 Sparks through the stubble: dying in a pandemic Rachel Clarke
437 [GO] 2021―Jul―01 Learning from crisis: building resilient systems to combat future pandemics Ilona Kickbusch, Gabriel M Leung, Robin J Shattock
438 [GO] 2021―Jun―28 AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC Emma C Wall, Mary Wu, Ruth Harvey, Gavin Kelly, Scott Warchal, Chelsea Sawyer, et al. (+18)
439 [GO] 2021―Jun―25 Heterologous vaccine regimens against COVID-19 Talita Duarte-Salles, Daniel Prieto-Alhambra
440 [GO] 2021―Jun―25 What constitutes success in the roll-out of COVID-19 vaccines? Maxwell J Smith
441 [GO] 2021―Jun―25 Pandemic response requires early and robust verification Susanna Lehtimaki, Pascale Allotey, Nina Schwalbe
442 [GO] 2021―Jun―25 More social discontent than pandemic-related risk perception in Colombia Alvaro J Idrovo
443 [GO] 2021―Jun―24 India's pain: beyond COVID-19 case numbers and mortality rates Rohini Dutta, Tarinee Kucchal
444 [GO] 2021―Jun―24 Can India's COVID-19 emergency be fixed without politics? Kunal Saha
445 [GO] 2021―Jun―24 India's COVID-19 emergency: overarching conclusions belie facts Dhavendra Kumar, Madhukar Mittal
446 [GO] 2021―Jun―24 India's COVID-19 response: science first Nita Radhakrishnan, Devendra Kumar Gupta
447 [GO] 2021―Jun―24 The complex causes of India's 2021 COVID-19 surge Aayush Visaria, Tina Dharamdasani
448 [GO] 2021―Jun―21 Addendum: competing interests and the origins of SARS-CoV-2 Editors of The Lancet
449 [GO] 2021―Jun―18 Five priorities for universal COVID-19 vaccination Adrien Abecassis
450 [GO] 2021―Jun―17 Protecting refugees during the COVID-19 pandemic The Lancet
451 [GO] 2021―Jun―14 SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness Aziz Sheikh, Jim McMenamin, Bob Taylor, Chris Robertson
452 [GO] 2021―Jun―11 SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia treated with immunoglobulin and argatroban Katharina Guetl, Thomas Gary, Reinhard B Raggam, Johannes Schmid, Albert Wölfler, Marianne Brodmann
453 [GO] 2021―Jun―10 Narrative complexity in the time of COVID-19 Aline Gubrium, Erika Gubrium
454 [GO] 2021―Jun―10 From routine data collection to policy design: sex and gender both matter in COVID-19 Mireille Evagora-Campbell, Kakoli Borkotoky, Sneha Sharma, Michelle Mbuthia
455 [GO] 2021―Jun―10 COVID-19 vaccine efficacy data: solid enough to delay second dose? - Authors' reply Sharon Amit, Gili Regev-Yochay, Arnon Afek, Yitshak Kreiss, Eyal Leshem
456 [GO] 2021―Jun―10 COVID-19 vaccine efficacy data: solid enough to delay second dose? John F R Robertson, Herb F Sewell
457 [GO] 2021―Jun―10 Anticoagulation in COVID-19: reaction to the ACTION trial Jeffrey S Berger, Jean Marie Connors
458 [GO] 2021―Jun―10 A strategy for SARS-CoV-2 vaccination in Yemen Abdullah Nasser, Fathiah Zakham
459 [GO] 2021―Jun―10 ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates Elizabeth T Rogawski McQuade, James A Platts-Mills
460 [GO] 2021―Jun―10 ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates - Authors' reply Merryn Voysey, Andrew J Pollard
461 [GO] 2021―Jun―08 Epidemiology, not geopolitics, should guide COVID-19 vaccine donations Thomas J Bollyky, Christopher J L Murray, Robert C Reiner
462 [GO] 2021―Jun―05 Bottom-up citizen engagement for health emergency and disaster risk management: directions since COVID-19 Emily Ying Yang Chan, Nina Gobat, Caroline Dubois, Jamie Bedson, Joao Rangel de Almeida
463 [GO] 2021―Jun―05 Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial Renato D Lopes, Pedro Gabriel Melo de Barros e Silva, Remo H M Furtado, Ariane Vieira Scarlatelli Macedo, Bruna Bronhara, Lucas Petri Damiani, et al. (+42)
464 [GO] 2021―Jun―03 The CEPI centralised laboratory network: supporting COVID-19 vaccine development Arun Kumar, Valentina Bernasconi, Mark Manak, Ana Paula de Almeida Aranha, Paul A Kristiansen
465 [GO] 2021―Jun―03 Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination Emma C Wall, Mary Wu, Ruth Harvey, Gavin Kelly, Scott Warchal, Chelsea Sawyer, et al. (+19)
466 [GO] 2021―Jun―02 Delayed COVID-19 vaccine roll-out in Japan Makoto Kosaka, Takanao Hashimoto, Akihiko Ozaki, Tetsuya Tanimoto, Masahiro Kami
467 [GO] 2021―Jun―01 A pandemic anniversary: 40 years of HIV/AIDS Chris Beyrer
468 [GO] 2021―May―29 Africa's need for more COVID-19 clinical trials Munyaradzi Makoni
469 [GO] 2021―May―29 Cambodia ends controversial COVID-19 restrictions Megan Tatum
470 [GO] 2021―May―28 Mutual aid, pandemic politics, and global social medicine in Brazil Dominique Béhague, Francisco Ortega
471 [GO] 2021―May―25 India's resurgence of COVID-19: urgent actions needed Yamini Aiyar, Vijay Chandru, Mirai Chatterjee, Sapna Desai, Armida Fernandez, Atul Gupta, et al. (+15)
472 [GO] 2021―May―21 Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): a multicentre, prospective, observational cohort study Bruce M Biccard, Pragasan Dean Gopalan, Malcolm Miller, William Lance Michell, David Thomson, Adesoji Ademuyiwa, et al. (+226)
473 [GO] 2021―May―21 What next for a COVID-19 intellectual property waiver? John Zarocostas
474 [GO] 2021―May―21 Excess COVID-19 mortality among critically ill patients in Africa Bruce J Kirenga, Pauline Byakika-Kibwika
475 [GO] 2021―May―21 Gendered effects of COVID-19 on young girls in regions of conflict Sophia N Nesamoney, Gary L Darmstadt, Paul H Wise
476 [GO] 2021―May―21 Refugee access to COVID-19 vaccines in Lebanon Nadine K Jawad, Lina Abu Taweeleh, Jad A Elharake, Nicole Khamis, Osaid Alser, Fatima M Karaki, Layla Aboukhater
477 [GO] 2021―May―14 India's COVID-19 crisis: a call for international action Krutika Kuppalli, Pooja Gala, Kartikeya Cherabuddi, S P Kalantri, Manoj Mohanan, Bhramar Mukherjee, et al. (+7)
478 [GO] 2021―May―14 Convalescent plasma in patients hospitalised with COVID-19 Sean T H Liu, Judith A Aberg
479 [GO] 2021―May―14 Disease surveillance for the COVID-19 era: time for bold changes Oliver W Morgan, Ximena Aguilera, Andrea Ammon, John Amuasi, Ibrahima Socé Fall, Tom Frieden, et al. (+10)
480 [GO] 2021―May―14 Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, Mustafa Abbas, Sadia Abbasi, Hakam Abbass, et al. (+7188)
481 [GO] 2021―May―13 COVID-19 in Turkey: a nation on edge Kaya Genç
482 [GO] 2021―May―13 Long-term effects of COVID-19 on kidney function Philipp Enghard, Jan-Hendrik Hardenberg, Helena Stockmann, Christian Hinze, Kai-Uwe Eckardt, Kai M Schmidt-Ott
483 [GO] 2021―May―13 Long-term effects of COVID-19 on kidney function Pierre Delanaye, Justine Huart, Antoine Bouquegneau, François Jouret
484 [GO] 2021―May―13 Long-term effects of COVID-19 on kidney function - Authors' reply Lixue Huang, Xiaoying Gu, Yeming Wang, Chaolin Huang, Bin Cao
485 [GO] 2021―May―13 Serbia begins paying citizens to receive a COVID-19 vaccine Ed Holt
486 [GO] 2021―May―13 Canada is no global health leader on COVID-19 vaccine equity Adam R Houston, Srinivas Murthy
487 [GO] 2021―May―13 Global COVID-19 vaccine roll-out: time to randomise vaccine allocation? Samuel I Watson, Richard J Lilford
488 [GO] 2021―May―13 Venezuela is collapsing without COVID-19 vaccines Enrique S López Loyo, Marino J González, José Esparza
489 [GO] 2021―May―12 Report of the Independent Panel for Pandemic Preparedness and Response: making COVID-19 the last pandemic Ellen Johnson Sirleaf, Helen Clark
490 [GO] 2021―May―12 Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data Robert H Shaw, Arabella Stuart, Melanie Greenland, Xinxue Liu, Jonathan S Nguyen Van-Tam, Matthew D Snape
491 [GO] 2021―May―07 LSE-Lancet Commission on the future of the NHS: re-laying the foundations for an equitable and efficient health and care service after COVID-19 Michael Anderson, Emma Pitchforth, Miqdad Asaria, Carol Brayne, Barbara Casadei, Anita Charlesworth, et al. (+28)
492 [GO] 2021―May―07 India's COVID-19 emergency The Lancet
493 [GO] 2021―May―07 Priorities for COVID-19 research response and preparedness in low-resource settings Alice Joan Norton, Charles Shey Wiysonge, Jean-Marie Vianney Habarugira, Nicholas John White, Marta Tufet Bayona, Hans-Eckhardt Hagen, et al. (+19)
494 [GO] 2021―May―07 COVID-19 surge threatens health in the Gaza strip Sharmila Devi
495 [GO] 2021―May―06 UK guidelines for managing long-term effects of COVID-19 Waqaar Shah, Melissa Heightman, Stella O'Brien
496 [GO] 2021―May―06 No-fault compensation schemes for COVID-19 medical products Yasuhiro Fujiwara, Yutaka Onda, Shuichiro Hayashi
497 [GO] 2021―May―05 Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data Eric J Haas, Frederick J Angulo, John M McLaughlin, Emilia Anis, Shepherd R Singer, Farid Khan, et al. (+9)
498 [GO] 2021―May―05 COVID-19 vaccine impact in Israel and a way out of the pandemic Eyal Leshem, Annelies Wilder-Smith
499 [GO] 2021―Apr―30 Experts criticise India's complacency over COVID-19 Anoo Bhuyan
500 [GO] 2021―Apr―30 Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, Mustafa Abbas, Sadia Abbasi, Hakam Abbass, et al. (+6343)
501 [GO] 2021―Apr―30 Tocilizumab in COVID-19: some clarity amid controversy Shruti Gupta, David E Leaf
502 [GO] 2021―Apr―30 COVID-19 and disparities affecting ethnic minorities Daniel R Morales, Sarah N Ali
503 [GO] 2021―Apr―30 Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform Rohini Mathur, Christopher T Rentsch, Caroline E Morton, William J Hulme, Anna Schultze, Brian MacKenna, et al. (+31)
504 [GO] 2021―Apr―28 SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties Miquel Oliu-Barton, Bary S R Pradelski, Philippe Aghion, Patrick Artus, Ilona Kickbusch, Jeffrey V Lazarus, et al. (+2)
505 [GO] 2021―Apr―28 A global pandemic treaty should aim for deep prevention Jorge Vinuales, Suerie Moon, Ginevra Le Moli, Gian-Luca Burci
506 [GO] 2021―Apr―23 COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study Victoria Jane Hall, Sarah Foulkes, Ayoub Saei, Nick Andrews, Blanche Oguti, Andre Charlett, et al. (+349)
507 [GO] 2021―Apr―23 Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study Eleftheria Vasileiou, Colin R Simpson, Ting Shi, Steven Kerr, Utkarsh Agrawal, Ashley Akbari, et al. (+26)
508 [GO] 2021―Apr―23 Hospital admissions due to COVID-19 in Scotland after one dose of vaccine Natalie Dean
509 [GO] 2021―Apr―20 The Swedish COVID-19 strategy revisited Mariam Claeson, Stefan Hanson
510 [GO] 2021―Apr―17 COVID-19: time for ethical reflection? Henri-Corto Stoeklé, Achille Ivasilevitch, Christian Hervé
511 [GO] 2021―Apr―16 Brazilian ICUs short of drugs and beds amid COVID-19 surge Lise Alves
512 [GO] 2021―Apr―16 Ten scientific reasons in support of airborne transmission of SARS-CoV-2 Trisha Greenhalgh, Jose L Jimenez, Kimberly A Prather, Zeynep Tufekci, David Fisman, Robert Schooley
513 [GO] 2021―Apr―16 Pandemic reading: poetry, looking and seeing Belinda Jack
514 [GO] 2021―Apr―15 Were pregnant women more affected by COVID-19 in the second wave of the pandemic? Suraj Kadiwar, Jonathan J Smith, Stephane Ledot, Mark Johnson, Paolo Bianchi, Natasha Singh, et al. (+4)
515 [GO] 2021―Apr―15 Tanzania's position on the COVID-19 pandemic Sayoki G Mfinanga, Nicholaus P Mnyambwa, Daniel T Minja, Nyanda Elias Ntinginya, Esther Ngadaya, Julie Makani, Abel N Makubi
516 [GO] 2021―Apr―15 Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination Antonios Bayas, Martina Menacher, Monika Christ, Lars Behrens, Andreas Rank, Markus Naumann
517 [GO] 2021―Apr―09 Correlates of protection from SARS-CoV-2 infection Florian Krammer
518 [GO] 2021―Apr―09 SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) Victoria Jane Hall, Sarah Foulkes, Andre Charlett, Ana Atti, Edward J Monk, Ruth Simmons, et al. (+323)
519 [GO] 2021―Apr―08 US-China health exchange and collaboration following COVID-19 Liming Li, Kean Wang, Zhuo Chen, Jeffrey P Koplan
520 [GO] 2021―Apr―08 China's response to COVID-19: a chance for collaboration The Lancet
521 [GO] 2021―Apr―08 Calls for transparency after SARS-CoV-2 origins report John Zarocostas
522 [GO] 2021―Apr―07 Ramadan and COVID-19 vaccine hesitancy-a call for action Sarah N Ali, Wasim Hanif, Kiran Patel, Kamlesh Khunti
523 [GO] 2021―Apr―02 Migration and health in Latin America during the COVID-19 pandemic and beyond Ietza Bojorquez, Báltica Cabieses, Carlos Arósquipa, Juan Arroyo, Andrés Cubillos Novella, Michael Knipper, et al. (+3)
524 [GO] 2021―Apr―02 COVID-19 vaccines in high-risk ethnic groups Rashmi S D'Souza, Ingrid Wolfe
525 [GO] 2021―Apr―02 Anterior uveitis in paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 Justin E R E Wong Chung, Ö Engin, T F W Wolfs, T J C Renson, J H de Boer
526 [GO] 2021―Apr―02 Leveraging data and new digital tools to prepare for the next pandemic Sally C Davies, Hala Audi, Mitch Cuddihy
527 [GO] 2021―Mar―31 Thromboembolism and the Oxford-AstraZeneca COVID-19 vaccine: side-effect or coincidence? Søren Dinesen Østergaard, Morten Schmidt, Erzsébet Horváth-Puhó, Reimar Wernich Thomsen, Henrik Toft Sørensen
528 [GO] 2021―Mar―31 Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial Katherine R W Emary, Tanya Golubchik, Parvinder K Aley, Cristina V Ariani, Brian Angus, Sagida Bibi, et al. (+58)
529 [GO] 2021―Mar―31 Pandemic moves and countermoves: vaccines and viral variants Rogier W Sanders, Menno D de Jong
530 [GO] 2021―Mar―25 COVID-19, cults, and the anti-vax movement Sophie Mylan, Charlotte Hardman
531 [GO] 2021―Mar―25 New COVID-19 resurgence in the WHO Eastern Mediterranean region Pierre Nabeth, Mahmoud Hassan, Keyrellous Adib, Abdinasir Abubakar, Richard Brennan
532 [GO] 2021―Mar―25 Uncertainties over EU COVID-19 vaccine sharing scheme Ann Danaiya Usher
533 [GO] 2021―Mar―25 COVID-19 vaccines for the European region: an unprecedented challenge Hans Kluge, Martin McKee
534 [GO] 2021―Mar―25 COVID-19: building a stronger Europe The Lancet
535 [GO] 2021―Mar―24 Gender, race, and health workers in the COVID-19 pandemic Gabriela Lotta, Michelle Fernandez, Denise Pimenta, Clare Wenham
536 [GO] 2021―Mar―24 Africa needs local solutions to face the COVID-19 pandemic Yap Boum, Lisa M Bebell, Anne-Cécile Zoung-Kanyi Bisseck
537 [GO] 2021―Mar―24 The first and second waves of the COVID-19 pandemic in Africa: a cross-sectional study Stephanie J Salyer, Justin Maeda, Senga Sembuche, Yenew Kebede, Akhona Tshangela, Mohamed Moussif, et al. (+5)
538 [GO] 2021―Mar―24 Human rights and fair access to COVID-19 vaccines: the International AIDS Society-Lancet Commission on Health and Human Rights Chris Beyrer, Pascale Allotey, Joseph J Amon, Stefan D Baral, Mary T Bassett, Harriet Deacon, et al. (+17)
539 [GO] 2021―Mar―23 Guidelines should not pool evidence from uncomplicated and severe COVID-19 Nicholas J White, Nathalie Strub-Wourgaft, Abul Faiz, Philippe J Guerin
540 [GO] 2021―Mar―23 Assessing government responsibility for COVID-19 deaths Adrian P Mundt
541 [GO] 2021―Mar―23 Rapid identification and tracking of SARS-CoV-2 variants of concern Debojyoti Chakraborty, Anurag Agrawal, Souvik Maiti
542 [GO] 2021―Mar―23 Vaccines and SARS-CoV-2 variants: the urgent need for a correlate of protection Salim S Abdool Karim
543 [GO] 2021―Mar―19 Biden's first legislative victory: $1·9 trillion for COVID-19 Susan Jaffe
544 [GO] 2021―Mar―19 COVID-19, community trials, and inclusion Paramjit S Gill, Shoba Poduval, Jarnail S Thakur, Romaina Iqbal
545 [GO] 2021―Mar―19 Free licensing of vaccines to end the COVID-19 crisis Kayvan Bozorgmehr, Rosa Jahn, David Stuckler, Martin McKee
546 [GO] 2021―Mar―19 Sustained neutralising antibodies in the Wuhan population suggest durable protection against SARS-CoV-2 Richard Strugnell, Nancy Wang
547 [GO] 2021―Mar―18 Triple jeopardy: disabled people and the COVID-19 pandemic Tom Shakespeare, Florence Ndagire, Queen E Seketi
548 [GO] 2021―Mar―18 Malnutrition risk in hospitalised COVID-19 patients receiving CPAP Pete Turner, Hugh Montgomery, Mike Stroud, George Grimble, Trevor Smith
549 [GO] 2021―Mar―18 Missing again: US racial and ethnic data for COVID-19 vaccination Nancy Krieger, Pamela D Waterman, Jarvis T Chen, Christian Testa, William P Hanage
550 [GO] 2021―Mar―18 Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study Christian Holm Hansen, Daniela Michlmayr, Sophie Madeleine Gubbels, Kåre Mølbak, Steen Ethelberg
551 [GO] 2021―Mar―18 Risk of SARS-CoV-2 reinfection after natural infection Rosemary J Boyton, Daniel M Altmann
552 [GO] 2021―Mar―12 School reopening without robust COVID-19 mitigation risks accelerating the pandemic Deepti Gurdasani, Nisreen A Alwan, Trisha Greenhalgh, Zoë Hyde, Luke Johnson, Martin McKee, et al. (+6)
553 [GO] 2021―Mar―12 A shared COVID-19 testimony Rageshri Dhairyawan
554 [GO] 2021―Mar―12 Countries split from EU on COVID-19 vaccines Ed Holt
555 [GO] 2021―Mar―12 Access to COVID-19 vaccines: looking beyond COVAX The Lancet
556 [GO] 2021―Mar―09 18Fluorodeoxyglucose PET/CT findings in a systemic inflammatory response syndrome after COVID-19 vaccine Julie Steinberg, Alex Thomas, Amir Iravani
557 [GO] 2021―Mar―07 The USA's response to the 2014 Ebola outbreak could have informed its COVID-19 response Syra Madad, Craig Spencer
558 [GO] 2021―Mar―07 Sex-disaggregated data in COVID-19 vaccine trials Lavanya Vijayasingham, Evelyne Bischof, Jeannette Wolfe
559 [GO] 2021―Mar―05 Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial Christopher C Butler, Jienchi Dorward, Ly-Mee Yu, Oghenekome Gbinigie, Gail Hayward, Benjamin R Saville, et al. (+12)
560 [GO] 2021―Mar―05 Medical oxygen crisis: a belated COVID-19 response Ann Danaiya Usher
561 [GO] 2021―Mar―05 Single-dose Oxford-AstraZeneca COVID-19 vaccine followed by a 12-week booster Ivan F N Hung, Gregory A Poland
562 [GO] 2021―Feb―26 New WTO leader faces COVID-19 challenges John Zarocostas
563 [GO] 2021―Feb―26 Historical evidence to inform COVID-19 vaccine mandates Rajaie Batniji
564 [GO] 2021―Feb―26 Peruvian COVID-19 vaccine scandal spreads Lucien Chauvin
565 [GO] 2021―Feb―26 Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine Maria Prendecki, Candice Clarke, Jonathan Brown, Alison Cox, Sarah Gleeson, Mary Guckian, et al. (+8)
566 [GO] 2021―Feb―26 Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals Charlotte Manisty, Ashley D Otter, Thomas A Treibel, Áine McKnight, Daniel M Altmann, Timothy Brooks, et al. (+4)
567 [GO] 2021―Feb―26 Offline: Thinking the pandemic Richard Horton
568 [GO] 2021―Feb―24 The changing face of medical professionalism and the impact of COVID-19 Andrew F Goddard, Mumtaz Patel
569 [GO] 2021―Feb―24 UK COVID-19 public inquiry and lessons from patient safety David K Whitaker
570 [GO] 2021―Feb―21 Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients Sharon Amit, Gili Regev-Yochay, Arnon Afek, Yitshak Kreiss, Eyal Leshem
571 [GO] 2021―Feb―21 MAb for symptomatic COVID-19 in correctional facilities: an important opportunity Justin Berk, Lauren Brinkley-Rubinstein, Matthew Murphy, Phil Chan, Josiah Rich
572 [GO] 2021―Feb―21 Same script, different viruses: HIV and COVID-19 in US Black communities Errol L Fields, Raniyah Copeland, Ernest Hopkins
573 [GO] 2021―Feb―21 von der Leyen admits to COVID-19 vaccine failures Rob Hyde
574 [GO] 2021―Feb―21 Severe mental illness: reassessing COVID-19 vaccine priorities Nayanah Siva
575 [GO] 2021―Feb―21 Rationale to continue approving placebo-controlled COVID-19 vaccine trials in LMICs Ivan Sisa, Estefania Noblecilla, Fadya Orozco
576 [GO] 2021―Feb―21 Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials Merryn Voysey, Sue Ann Costa Clemens, Shabir A Madhi, Lily Y Weckx, Pedro M Folegatti, Parvinder K Aley, et al. (+760)
577 [GO] 2021―Feb―18 Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19 Michael J Mina, Tim E Peto, Marta García-Fiñana, Malcolm G Semple, Iain E Buchan
578 [GO] 2021―Feb―17 Future scenarios for the COVID-19 pandemic David Skegg, Peter Gluckman, Geoffrey Boulton, Heide Hackmann, Salim S Abdool Karim, Peter Piot, Christiane Woopen
579 [GO] 2021―Feb―15 Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment Olivier J Wouters, Kenneth C Shadlen, Maximilian Salcher-Konrad, Andrew J Pollard, Heidi J Larson, Yot Teerawattananon, Mark Jit
580 [GO] 2021―Feb―15 Priorities for the COVID-19 pandemic at the start of 2021: statement of the Lancet COVID-19 Commission Jeffrey D Sachs, Salim Abdool Karim, Lara Aknin, Joseph Allen, Kirsten Brosbøl, Gabriela Cuevas Barron, et al. (+30)
581 [GO] 2021―Feb―11 COVID-19 in Brazil: far beyond biopolitics Rafael Dall'Alba, Cristianne Famer Rocha, Roberta de Pinho Silveira, Liciane da Silva Costa Dresch, Luciana Araújo Vieira, Marco André Germanò
582 [GO] 2021―Feb―11 SARS-CoV-2 variants and ending the COVID-19 pandemic Arnaud Fontanet, Brigitte Autran, Bruno Lina, Marie Paule Kieny, Salim S Abdool Karim, Devi Sridhar
583 [GO] 2021―Feb―11 Tanzania refuses COVID-19 vaccines Munyaradzi Makoni
584 [GO] 2021―Feb―10 Ensure Palestinians have access to COVID-19 vaccines Steven Martin, Thalia Arawi
585 [GO] 2021―Feb―05 Offline: COVID-19 and the convergence of nations Richard Horton
586 [GO] 2021―Feb―05 Calling for benefit-risk evaluations of COVID-19 control measures Günter Kampf, Martin Kulldorff
587 [GO] 2021―Feb―05 A COVID-19 jab in the right direction A Mark Clarfield, Karl Skorecki, Orly Manor, Shimon Glick
588 [GO] 2021―Feb―05 WHO team begins COVID-19 origin investigation John Zarocostas
589 [GO] 2021―Feb―05 WHO international non-proprietary names: the need to distinguish COVID-19 vaccines Ursula Loizides, Akinola Adisa, Ana López de la Rica Manjavacas, James S Robertson, Raffaella Balocco
590 [GO] 2021―Feb―05 Understanding variants of SARS-CoV-2 Talha Burki
591 [GO] 2021―Feb―05 Genomic sequencing in pandemics The Lancet
592 [GO] 2021―Feb―05 Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi, Alfie Abbott, Ashraf Abdelaziz, Sherif Abdelbadiee, et al. (+5364)
593 [GO] 2021―Feb―02 COVID-19, structural racism, and migrant health in Canada Germaine Tuyisenge, Shira M Goldenberg
594 [GO] 2021―Feb―02 Sputnik V COVID-19 vaccine candidate appears safe and effective Ian Jones, Polly Roy
595 [GO] 2021―Feb―02 COVID-19 vaccine research and the trouble with clinical equipoise Phoebe Friesen, Arthur L Caplan, Jennifer E Miller
596 [GO] 2021―Feb―02 Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia Denis Y Logunov, Inna V Dolzhikova, Dmitry V Shcheblyakov, Amir I Tukhvatulin, Olga V Zubkova, Alina S Dzharullaeva, et al. (+25)
597 [GO] 2021―Jan―29 Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial Peter Richmond, Lara Hatchuel, Min Dong, Brenda Ma, Branda Hu, Igor Smolenov, et al. (+5)
598 [GO] 2021―Jan―29 Next-generation COVID-19 vaccines: here come the proteins Anna K Blakney, Paul F McKay
599 [GO] 2021―Jan―28 Urgent needs of low-income and middle-income countries for COVID-19 vaccines and therapeutics J Peter Figueroa, Maria Elena Bottazzi, Peter Hotez, Carolina Batista, Onder Ergonul, Sarah Gilbert, et al. (+12)
600 [GO] 2021―Jan―28 COVID-19 vaccines for Palestinians Graham Watt, Rita Giacaman, Huda Zurayk, Espen Bjertness, Gerd Holmboe-Ottesen, Hala Ghattas, et al. (+8)
601 [GO] 2021―Jan―28 Caring intensively: a GP's pandemic journal Rachel Clarke
602 [GO] 2021―Jan―28 SARS-CoV-2 serosurveys in low-income and middle-income countries Jean Claude Mugunga, Kartik Tyagi, Daniel Bernal-Serrano, Nidia Correa, Matias Iberico, Frederick Kateera, et al. (+4)
603 [GO] 2021―Jan―27 Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence Ester C Sabino, Lewis F Buss, Maria P S Carvalho, Carlos A Prete, Myuki A E Crispim, Nelson A Fraiji, et al. (+17)
604 [GO] 2021―Jan―25 The need for a global COVID-19 maternal immunisation research plan Azucena Bardají, Esperança Sevene, Clare Cutland, Clara Menéndez, Saad B Omer, Teresa Aguado, Flor M Muñoz
605 [GO] 2021―Jan―22 COVID-19 and the moral imagination Mahomed Said Patel, Christine Beatrice Phillips
606 [GO] 2021―Jan―22 Reaffirming health and safety precautionary principles for COVID-19 in the UK Raymond M Agius, Denise Kendrick, Herb F Sewell, Marcia Stewart, John FR Robertson
607 [GO] 2021―Jan―22 India begins COVID-19 vaccination amid trial allegations Anoo Bhuyan
608 [GO] 2021―Jan―22 COVID-19: the intersection of education and health The Lancet
609 [GO] 2021―Jan―22 Neuropathology associated with SARS-CoV-2 infection Kristof Egervari, Christian Thomas, Johannes A Lobrinus, Tanja Kuhlmann, Wolfgang Brück, Seth Love, et al. (+4)
610 [GO] 2021―Jan―22 Neuropathology associated with SARS-CoV-2 infection MacLean P Nasrallah, Zissimos Mourelatos, Edward B Lee
611 [GO] 2021―Jan―22 Neuropathology associated with SARS-CoV-2 infection Markus Glatzel, Christian Hagel, Jakob Matschke, Jan Sperhake, Nikolaus Deigendesch, Alexandar Tzankov, Stephan Frank
612 [GO] 2021―Jan―22 Neuropathology associated with SARS-CoV-2 infection - Authors' reply Claus Hann von Weyhern, Ines Kaufmann, Frauke Neff, Marcus Kremer
613 [GO] 2021―Jan―22 South Africa responds to new SARS-CoV-2 variant Munyaradzi Makoni
614 [GO] 2021―Jan―21 An action plan for pan-European defence against new SARS-CoV-2 variants Viola Priesemann, Rudi Balling, Melanie M Brinkmann, Sandra Ciesek, Thomas Czypionka, Isabella Eckerle, et al. (+11)
615 [GO] 2021―Jan―20 Preparing for a COVID-19 resurgence in the WHO African region Benido Impouma, Franck Mboussou, Francis Kasolo, Zabulon Yoti, Matshidiso R Moeti
616 [GO] 2021―Jan―15 COVID-19 highlights Canada's care home crisis Paul Webster
617 [GO] 2021―Jan―15 Using EM data to understand COVID-19 pathophysiology Marisa Dolhnikoff, Amaro N Duarte-Neto, Paulo H N Saldiva, Elia G Caldini
618 [GO] 2021―Jan―15 Using EM data to understand COVID-19 pathophysiology - Authors' reply Carsten Dittmayer, Jenny Meinhardt, Helena Radbruch, Josefine Radke, Barbara Ingold Heppner, Frank L Heppner, et al. (+3)
619 [GO] 2021―Jan―14 The European Medicines Agency's EU conditional marketing authorisations for COVID-19 vaccines Marco Cavaleri, Harald Enzmann, Sabine Straus, Emer Cooke
620 [GO] 2021―Jan―11 Long-term follow-up of recovered patients with COVID-19 Monica Cortinovis, Norberto Perico, Giuseppe Remuzzi
621 [GO] 2021―Jan―11 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study Chaolin Huang, Lixue Huang, Yeming Wang, Xia Li, Lili Ren, Xiaoying Gu, et al. (+26)
622 [GO] 2021―Jan―08 Parenting in the time of COVID-19 Shana Kusin, Esther Choo
623 [GO] 2021―Jan―08 Health systems neglected by COVID-19 donors Ann Danaiya Usher
624 [GO] 2021―Jan―08 ECMO support for COVID-19: a balancing act Yang Zhang, Bingyang Ji, Zhou Zhou
625 [GO] 2021―Jan―08 ECMO support for COVID-19: a balancing act - Authors' reply Ryan P Barbaro, Graeme MacLaren, Daniel Brodie
626 [GO] 2020―Dec―23 COVID-19 and the Swedish enigma Mariam Claeson, Stefan Hanson
627 [GO] 2020―Dec―23 UK COVID-19 public inquiry needed to learn lessons and save lives Jo Goodman, Kathryn de Prudhoe, Charlie Williams
628 [GO] 2020―Dec―23 COVID-19 vaccines and women's security Sophie Harman, Asha Herten-Crabb, Rosemary Morgan, Julia Smith, Clare Wenham
629 [GO] 2020―Dec―18 Offline: The lessons of smallpox eradication for COVID-19 Richard Horton
630 [GO] 2020―Dec―18 Infectivity of asymptomatic versus symptomatic COVID-19 Andrew A Sayampanathan, Cheryl S Heng, Phua Hwee Pin, Junxiong Pang, Teoh Yee Leong, Vernon J Lee
631 [GO] 2020―Dec―18 Science during COVID-19: where do we go from here? The Lancet
632 [GO] 2020―Dec―18 Calling for pan-European commitment for rapid and sustained reduction in SARS-CoV-2 infections Viola Priesemann, Melanie M Brinkmann, Sandra Ciesek, Sarah Cuschieri, Thomas Czypionka, Giulia Giordano, et al. (+14)
633 [GO] 2020―Dec―16 Pay gaps in medicine and the impact of COVID-19 on doctors' careers Carol Woodhams, Jane Dacre, Ira Parnerkar, Mukunda Sharma
634 [GO] 2020―Dec―16 Reduced mortality in New Zealand during the COVID-19 pandemic Stacey Kung, Marjan Doppen, Melissa Black, Tom Hills, Nethmi Kearns
635 [GO] 2020―Dec―16 Buyer beware: inflated claims of sensitivity for rapid COVID-19 tests Meagan C Fitzpatrick, Abhishek Pandey, Chad R Wells, Pratha Sah, Alison P Galvani
636 [GO] 2020―Dec―11 Maintaining a gendered perspective in scientific meetings during the COVID-19 pandemic Berit Lange
637 [GO] 2020―Dec―11 Experts call to include prisons in COVID-19 vaccine plans Nayanah Siva
638 [GO] 2020―Dec―11 The COVID-19 vaccines rush: participatory community engagement matters more than ever Rochelle Ann Burgess, Richard H Osborne, Kenneth A Yongabi, Trisha Greenhalgh, Deepti Gurdasani, Gagandeep Kang, et al. (+6)
639 [GO] 2020―Dec―11 Is my cough COVID-19? Eric J Topol
640 [GO] 2020―Dec―11 Association of SARS-CoV-2 renal tropism with acute kidney injury Kay Weng Choy
641 [GO] 2020―Dec―11 Association of SARS-CoV-2 renal tropism with acute kidney injury - Authors' reply Fabian Braun, Carolin Edler, Victor G Puelles, Tobias B Huber
642 [GO] 2020―Dec―11 The infective nurture of pandemic comics Ciléin Kearns, Dale Fisher, Yap Seng Chong
643 [GO] 2020―Dec―11 One Health or Planetary Health for pandemic prevention? Courtney Waugh, Su Shiung Lam, Christian Sonne
644 [GO] 2020―Dec―11 One Health or Planetary Health for pandemic prevention? - Authors' reply John H Amuasi, Andrea S Winkler
645 [GO] 2020―Dec―08 Oxford-AstraZeneca COVID-19 vaccine efficacy Maria Deloria Knoll, Chizoba Wonodi
646 [GO] 2020―Dec―08 Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK Merryn Voysey, Sue Ann Costa Clemens, Shabir A Madhi, Lily Y Weckx, Pedro M Folegatti, Parvinder K Aley, et al. (+757)
647 [GO] 2020―Dec―04 Is NHS Test and Trace exacerbating COVID-19 inequalities? Adam D M Briggs, Caroline Fraser
648 [GO] 2020―Dec―03 An African plan to control COVID-19 is urgently needed The Lancet
649 [GO] 2020―Dec―03 South Africa and India push for COVID-19 patents ban Ann Danaiya Usher
650 [GO] 2020―Dec―03 Offline: COVID-19-what have we learned so far? Richard Horton
651 [GO] 2020―Dec―02 Climate and COVID-19: converging crises The Lancet
652 [GO] 2020―Dec―01 Fragmented health systems in COVID-19: rectifying the misalignment between global health security and universal health coverage Arush Lal, Ngozi A Erondu, David L Heymann, Githinji Gitahi, Robert Yates
653 [GO] 2020―Nov―30 Centring adolescent girls and young women in the HIV and COVID-19 responses Ameena Goga, Linda Gail Bekker, Philippe Van de Perre, Wafaa El-Sadr, Khatija Ahmed, Mookho Malahleha, et al. (+4)
654 [GO] 2020―Nov―26 Applying for residency in the time of COVID-19 Tema Fodje, Esther Choo
655 [GO] 2020―Nov―26 A tribute to some of the doctors who died from COVID-19 Andrew Green
656 [GO] 2020―Nov―26 Maintaining the HIV response in a world shaped by COVID-19 The Lancet
657 [GO] 2020―Nov―26 Afghanistan braced for second wave of COVID-19 Sophie Cousins
658 [GO] 2020―Nov―26 Offline: Europe and COVID-19-struggling with tragedy Richard Horton
659 [GO] 2020―Nov―24 Smart system of disease management for patient follow-up and medication refill during the COVID-19 epidemic period: a multicentre retrospective cohort study Lingli Dong, Anbin Huang, Shengtao Zhang, Yikai Yu, Shouxin li, Lingxun Shen, et al. (+4)
660 [GO] 2020―Nov―24 The attitude and psychological status of medical staff in China during the COVID-19 outbreak: a cross-sectional survey Ziyi Yan, Yali Cui, Wen Chen, Mingjing Yu, Qichen Long, Yunyi Yuan, et al. (+4)
661 [GO] 2020―Nov―20 Urgent actions and policies needed to address COVID-19 among UK ethnic minorities Rohini Mathur, Laura Bear, Kamlesh Khunti, Rosalind M Eggo
662 [GO] 2020―Nov―20 Tackling COVID-19 in the Eastern Mediterranean Region Ahmed Salim Al-Mandhari, Richard J Brennan, Abdinasir Abubakar, Rana Hajjeh
663 [GO] 2020―Nov―20 COVID-19 vaccines: no time for complacency The Lancet
664 [GO] 2020―Nov―20 Notice of addendum to Article reporting Oxford trial of ChAdOx1 nCoV-19 vaccine Andrew J Pollard
665 [GO] 2020―Nov―19 Age and frailty in COVID-19 vaccine development Melissa K Andrew, Janet E McElhaney
666 [GO] 2020―Nov―19 Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial Maheshi N Ramasamy, Angela M Minassian, Katie J Ewer, Amy L Flaxman, Pedro M Folegatti, Daniel R Owens, et al. (+406)
667 [GO] 2020―Nov―12 Leveraging the COVID-19 response to end preventable child deaths from pneumonia Henrietta H Fore, Tedros Adhanom Ghebreyesus, Kevin Watkins, Leith Greenslade, Seth Berkley, Quique Bassat, et al. (+3)
668 [GO] 2020―Nov―12 Staying sane in our new COVID-19 world Devi Sridhar
669 [GO] 2020―Nov―10 COVID-19 in Brazil: the headlines should be about science André Zimerman, Renato D Lopes, André D'Ávila, Luis E Rohde, Leandro I Zimerman
670 [GO] 2020―Nov―09 The UK needs a sustainable strategy for COVID-19 Deepti Gurdasani, Laura Bear, Debby Bogaert, Rochelle A Burgess, Reinhard Busse, Roberto Cacciola, et al. (+30)
671 [GO] 2020―Nov―06 Early triple antiviral therapy for COVID-19 Nelson Lee, Michael Ison, Jake Dunning
672 [GO] 2020―Nov―06 Early triple antiviral therapy for COVID-19 - Authors' reply Ivan Fan-Ngai Hung, Kwok-Yung Yuen
673 [GO] 2020―Nov―06 COVID-19 in Latin America: a humanitarian crisis The Lancet
674 [GO] 2020―Nov―06 Strategy, coordinated implementation, and sustainable financing needed for COVID-19 innovations Victor J Dzau, Celynne Balatbat
675 [GO] 2020―Nov―06 Institutional versus home isolation to curb the COVID-19 outbreak Ajeet Singh Bhadoria, Kanchan Gawande, Rachit Sharma, Archisman Mohapatra, Ravi Kant
676 [GO] 2020―Nov―06 Institutional versus home isolation to curb the COVID-19 outbreak - Authors' reply Annelies Wilder-Smith, Alex R Cook, Borame L Dickens
677 [GO] 2020―Nov―06 Surgery during the COVID-19 pandemic Lewis Meecham, Julien Al Shakarchi, Habib P Rahman, Isaac K Nyamekye
678 [GO] 2020―Nov―06 Surgery during the COVID-19 pandemic Seenu Vuthaluru, Sreedharan V Koliyadan, Sureshkannan S Kanniwadi
679 [GO] 2020―Nov―06 Surgery during the COVID-19 pandemic Harsha Shanthanna, Vishal Uppal
680 [GO] 2020―Nov―06 Surgery during the COVID-19 pandemic Jeremy Rodrigues, James K-K Chan, Fadi Issa
681 [GO] 2020―Nov―06 Surgery during the COVID-19 pandemic Joseph Alderman
682 [GO] 2020―Nov―06 Surgery during the COVID-19 pandemic Hytham K S Hamid
683 [GO] 2020―Nov―06 Surgery during the COVID-19 pandemic - Authors' reply COVIDSurg Collaborative
684 [GO] 2020―Nov―06 Offline: Managing the COVID-19 vaccine infodemic Richard Horton
685 [GO] 2020―Nov―06 Emergency use authorisation for COVID-19 vaccines: lessons from Ebola Maxwell J Smith, Samuel Ujewe, Rachel Katz, Ross E G Upshur
686 [GO] 2020―Nov―06 ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 Archie Lodge
687 [GO] 2020―Nov―06 ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 Anil Chauhan, Amit Agarwal, Nishant Jaiswal, Meenu Singh
688 [GO] 2020―Nov―06 ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 - Authors' reply Merryn Voysey, Andrew J Pollard
689 [GO] 2020―Nov―06 SARS-CoV-2 seroprevalence in Spain Christian Hoffmann, Eva Wolf
690 [GO] 2020―Nov―06 SARS-CoV-2 seroprevalence in Spain Thukalan Paulose George
691 [GO] 2020―Nov―06 SARS-CoV-2 seroprevalence in Spain - Authors' reply Marina Pollán, Beatriz Pérez-Gómez, Roberto Pastor-Barriuso, Jesús Oteo, Mayte Pérez-Olmeda, Raquel Yotti
692 [GO] 2020―Nov―05 Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination Roy M Anderson, Carolin Vegvari, James Truscott, Benjamin S Collyer
693 [GO] 2020―Nov―03 Widespread smell testing for COVID-19 has limited application Claire Hopkins, Barry Smith
694 [GO] 2020―Nov―03 Widespread smell testing for COVID-19 has limited application - Authors' reply Cristina Menni, Carole H Sudre, Claire J Steves, Sebastien Ourselin, Tim D Spector
695 [GO] 2020―Oct―30 Asymptomatic health-care worker screening during the COVID-19 pandemic Angela Chow, Htet Lin Htun, Win Mar Kyaw, Lay Tin Lee, Brenda Ang
696 [GO] 2020―Oct―30 Organ procurement and transplantation in Germany during the COVID-19 pandemic Zhi Qu, Carina Oedingen, Tim Bartling, Harald Schrem, Christian Krauth
697 [GO] 2020―Oct―30 Asymptomatic health-care worker screening during the COVID-19 pandemic Kevin Fennelly, Christopher C Whalen
698 [GO] 2020―Oct―30 Asymptomatic health-care worker screening during the COVID-19 pandemic - Authors' reply Thomas A Treibel, Charlotte Manisty, Mervyn Andiapen, Corinna Pade, Melanie Jensen, Marianna Fontana, et al. (+4)
699 [GO] 2020―Oct―30 Host or pathogen-related factors in COVID-19 severity? Christian Gortázar, Francisco J Rodríguez del-Río, Lucas Domínguez, José de la Fuente
700 [GO] 2020―Oct―30 Host or pathogen-related factors in COVID-19 severity? - Authors' reply Lucy C Okell, Robert Verity, Aris Katzourakis, Erik M Volz, Oliver J Watson, Swapnil Mishra, et al. (+9)
701 [GO] 2020―Oct―30 Offline: COVID-19-a crisis of power Richard Horton
702 [GO] 2020―Oct―30 Slovakia to test all adults for SARS-CoV-2 Ed Holt
703 [GO] 2020―Oct―30 Transplant programmes in areas with high SARS-CoV-2 transmission Srikanth Reddy, Richard Dumbill, M Zeeshan Akhtar, Venkatesha Udupa, Ben M Storey, James Gilbert, et al. (+12)
704 [GO] 2020―Oct―27 Syndemic responses to COVID-19 should include an ecological dimension Chris Kenyon
705 [GO] 2020―Oct―27 Maintaining confidentiality of emerging results in COVID-19 vaccine trials is essential Philip R Krause, Thomas R Fleming, Susan S Ellenberg, Ana Maria Henao-Restrepo, PR Krause, T Fleming, et al. (+10)
706 [GO] 2020―Oct―27 Who should be prioritised for COVID-19 vaccines? Zaki Hassan-Smith, Wasim Hanif, Kamlesh Khunti
707 [GO] 2020―Oct―23 Experts criticise Australia's aged care failings over COVID-19 Sophie Cousins
708 [GO] 2020―Oct―23 Offline: Science and politics in the era of COVID-19 Richard Horton
709 [GO] 2020―Oct―23 US racial and ethnic data for COVID-19 cases: still missing in action Nancy Krieger, Christian Testa, William P Hanage, Jarvis T Chen
710 [GO] 2020―Oct―23 SARS-CoV-2 risk misclassification explains poor COVID-19 management Juan Martínez Hernández
711 [GO] 2020―Oct―23 Building a tuberculosis-free world while responding to the COVID-19 pandemic Michael J A Reid, Sachin Silva, Nimalan Arinaminpathy, Eric Goosby
712 [GO] 2020―Oct―23 Influenza control during the COVID-19 pandemic Thomas Hills, Nethmi Kearns, Ciléin Kearns, Richard Beasley
713 [GO] 2020―Oct―23 The COVID-19 syndemic is not global: context matters Emily Mendenhall
714 [GO] 2020―Oct―23 Misuse of SARS-CoV-2 testing in symptomatic health-care staff in the UK - Authors' reply James R M Black, Chris Bailey, Joanna Przewrocka, Krijn K Dijkstra, Sonia Gandhi, Steve Gamblin, et al. (+2)
715 [GO] 2020―Oct―23 Misuse of SARS-CoV-2 testing in symptomatic health-care staff in the UK Bernard Freudenthal
716 [GO] 2020―Oct―20 The Brazilian Government's mistakes in responding to the COVID-19 pandemic Sabrina Ferigato, Michelle Fernandez, Melania Amorim, Ilana Ambrogi, Luísa M M Fernandes, Rafaela Pacheco
717 [GO] 2020―Oct―20 Evidence synthesis communities in low-income and middle-income countries and the COVID-19 response Ruth Stewart, Amena El-Harakeh, Sunu Alice Cherian
718 [GO] 2020―Oct―19 Science misuse and polarised political narratives in the COVID-19 response Rômulo Paes-Sousa, Christopher Millett, Rudi Rocha, Mauricio L Barreto, Thomas Hone
719 [GO] 2020―Oct―16 Unnecessary obstacles to COVID-19 mass testing Julian Peto, David J Hunter, Elio Riboli, Julian L Griffin
720 [GO] 2020―Oct―15 The Lombardy region of Italy launches the first investigative COVID-19 commission Michele Usuelli
721 [GO] 2020―Oct―15 Scientific consensus on the COVID-19 pandemic: we need to act now Nisreen A Alwan, Rochelle Ann Burgess, Simon Ashworth, Rupert Beale, Nahid Bhadelia, Debby Bogaert, et al. (+25)
722 [GO] 2020―Oct―13 SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates Gregory A Poland, Inna G Ovsyannikova, Richard B Kennedy
723 [GO] 2020―Oct―12 Taking pandemic sequelae seriously: from the Russian influenza to COVID-19 long-haulers Mark Honigsbaum, Lakshmi Krishnan
724 [GO] 2020―Oct―09 Steroids for sepsis and ARDS: this eternal controversy remains with COVID-19 Jean Carlet, Didier Payen, Steven M Opal
725 [GO] 2020―Oct―08 Cancer and COVID-19 Dimitrios Moris, Diamantis I Tsilimigras, Dimitrios Schizas
726 [GO] 2020―Oct―08 Cancer and COVID-19 Alexandre E Malek, Issam I Raad, Elias Jabbour
727 [GO] 2020―Oct―08 Cancer and COVID-19 - Authors' reply Nicole M Kuderer, Elizabeth Wulff-Burchfield, Samuel M Rubinstein, Petros Grivas, Jeremy L Warner
728 [GO] 2020―Oct―08 Is COVID-19 being used as a weapon against Indigenous Peoples in Brazil? Philippe Charlier, Leandro Varison
729 [GO] 2020―Oct―08 COVID-19, comics, and the visual culture of contagion Brian Callender, Shirlene Obuobi, M K Czerwiec, Ian Williams
730 [GO] 2020―Oct―08 Study of critically ill patients with COVID-19 in New York City Daniele Piovani, Stefanos Bonovas
731 [GO] 2020―Oct―08 Study of critically ill patients with COVID-19 in New York City - Authors' reply Matthew J Cummings, Max R O'Donnell
732 [GO] 2020―Oct―08 Undermining breastfeeding will not alleviate the COVID-19 pandemic Natalie S Shenker, Aleksandra Wesolowska, Johannes B van Goudoever, Sushma Nangia, Daniel Klotz
733 [GO] 2020―Oct―08 2·5 million more child marriages due to COVID-19 pandemic Sophie Cousins
734 [GO] 2020―Oct―08 Marketing of breastmilk substitutes during the COVID-19 pandemic Christoffer van Tulleken, Charlotte Wright, Amy Brown, David McCoy, Anthony Costello
735 [GO] 2020―Oct―08 Undermining breastfeeding will not alleviate the COVID-19 pandemic - Authors' reply Rüdiger Groß, Carina Conzelmann, Janis A Müller, Frank Reister, Frank Kirchhoff, Jan Münch
736 [GO] 2020―Oct―08 Living with the COVID-19 pandemic: act now with the tools we have Juliet Bedford, Delia Enria, Johan Giesecke, David L Heymann, Chikwe Ihekweazu, Gary Kobinger, et al. (+6)
737 [GO] 2020―Oct―08 COVID-19: leaving no one behind in Latin America Alice Blukacz, Baltica Cabieses
738 [GO] 2020―Oct―05 Antiviral monotherapy for hospitalised patients with COVID-19 is not enough Bin Cao, Frederick G Hayden
739 [GO] 2020―Oct―05 Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Peter W Horby, Marion Mafham, Jennifer L Bell, Louise Linsell, Natalie Staplin, Jonathan Emberson, et al. (+20)
740 [GO] 2020―Oct―05 Power of and power over COVID-19 response guidelines Kayvan Bozorgmehr
741 [GO] 2020―Oct―05 Why misinterpretation of electron micrographs in SARS-CoV-2-infected tissue goes viral Carsten Dittmayer, Jenny Meinhardt, Helena Radbruch, Josefine Radke, Barbara Ingold Heppner, Frank L Heppner, et al. (+3)
742 [GO] 2020―Oct―01 Leveraging the advances in HIV for COVID-19 James H McMahon, Jennifer F Hoy, Adeeba Kamarulzaman, Linda-Gail Bekker, Chris Beyrer, Sharon R Lewin
743 [GO] 2020―Oct―01 Remdesivir and COVID-19 Matthew J Glaus, Serena Von Ruden
744 [GO] 2020―Oct―01 Remdesivir and COVID-19 Jessie K Edwards, Stephen R Cole, Adaora A Adimora
745 [GO] 2020―Oct―01 Remdesivir and COVID-19 Lei-Yun Wang, Jia-Jia Cui, Qian-Ying Ouyang, Yan Zhan, Cheng-Xian Guo, Ji-Ye Yin
746 [GO] 2020―Oct―01 Remdesivir and COVID-19 Alicia Dennis
747 [GO] 2020―Oct―01 Remdesivir and COVID-19 - Authors' reply Yeming Wang, Xiaoying Gu, Jiuyang Xu, Bin Cao, Chen Wang
748 [GO] 2020―Oct―01 Building a resilient NHS, for COVID-19 and beyond The Lancet
749 [GO] 2020―Oct―01 Minimising long-term effect of COVID-19 in dementia care Karen Harrison Dening, Mari Lloyd-Williams
750 [GO] 2020―Sep―29 Lockdown impact on COVID-19 epidemics in regions across metropolitan France Simon Cauchemez, Cécile Tran Kiem, Juliette Paireau, Patrick Rolland, Arnaud Fontanet
751 [GO] 2020―Sep―29 Confronting antimicrobial resistance beyond the COVID-19 pandemic and the 2020 US election Steffanie A Strathdee, Sally C Davies, Jasmine R Marcelin
752 [GO] 2020―Sep―25 Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry Ryan P Barbaro, Graeme MacLaren, Philip S Boonstra, Theodore J Iwashyna, Arthur S Slutsky, Eddy Fan, et al. (+195)
753 [GO] 2020―Sep―25 Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study Shuchi Anand, Maria Montez-Rath, Jialin Han, Julie Bozeman, Russell Kerschmann, Paul Beyer, et al. (+2)
754 [GO] 2020―Sep―25 SARS-CoV-2 antibody seroprevalence in patients receiving dialysis in the USA Barnaby Flower, Christina Atchison
755 [GO] 2020―Sep―24 David Hare's fiery account of COVID-19 Philip Ball
756 [GO] 2020―Sep―24 COVID-19 in India: the dangers of false optimism The Lancet
757 [GO] 2020―Sep―24 Offline: COVID-19 is not a pandemic Richard Horton
758 [GO] 2020―Sep―24 Models for mortality require tailoring in the context of the COVID-19 pandemic Arielle Lasry, Roberta Horth
759 [GO] 2020―Sep―24 Israeli aid to the West Bank and the Gaza Strip during the COVID-19 pandemic Zion Hagay
760 [GO] 2020―Sep―24 Models for mortality require tailoring in the context of the COVID-19 pandemic - Authors' reply Amitava Banerjee, Laura Pasea, Spiros Denaxas, Bryan Williams, Harry Hemingway
761 [GO] 2020―Sep―24 Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe Emeline Han, Melisa Mei Jin Tan, Eva Turk, Devi Sridhar, Gabriel M Leung, Kenji Shibuya, et al. (+11)
762 [GO] 2020―Sep―22 The Riyadh Declaration: the role of digital health in fighting pandemics Bandar Al Knawy, Mahmood Adil, George Crooks, Kyu Rhee, David Bates, Hani Jokhdar, et al. (+7)
763 [GO] 2020―Sep―21 Safety and efficacy of the Russian COVID-19 vaccine: more information needed Enrico Bucci, Konstantin Andreev, Anders Björkman, Raffaele Adolfo Calogero, Ernesto Carafoli, Piero Carninci, et al. (+10)
764 [GO] 2020―Sep―21 Safety and efficacy of the Russian COVID-19 vaccine: more information needed - Authors’ reply Denis Y Logunov, Inna V Dolzhikova, Amir I Tukhvatullin, Dmitry V Shcheblyakov
765 [GO] 2020―Sep―21 What can we expect from first-generation COVID-19 vaccines? Malik Peiris, Gabriel M Leung
766 [GO] 2020―Sep―17 Seeking clarity on retinal findings in patients with COVID-19 Elia J Duh
767 [GO] 2020―Sep―17 Seeking clarity on retinal findings in patients with COVID-19 Frederick T Collison, Joseph Carroll
768 [GO] 2020―Sep―17 Seeking clarity on retinal findings in patients with COVID-19 Camilo Brandão-de-Resende, Alberto Diniz-Filho, Daniel V Vasconcelos-Santos
769 [GO] 2020―Sep―17 Seeking clarity on retinal findings in patients with COVID-19 Pingbo Ouyang, Xinyu Zhang, Yinghui Peng, Bing Jiang
770 [GO] 2020―Sep―17 Seeking clarity on retinal findings in patients with COVID-19 Pradeep Venkatesh
771 [GO] 2020―Sep―17 Seeking clarity on retinal findings in patients with COVID-19 - Authors' reply Paula M Marinho, Heloisa Nascimento, Allexya A A Marcos, André C Romano, Rubens Belfort
772 [GO] 2020―Sep―17 Understanding Mexican health worker COVID-19 deaths David Agren
773 [GO] 2020―Sep―17 Brazil's COVID-19 response Maria Helena da Silva Bastos
774 [GO] 2020―Sep―17 Brazil's COVID-19 response Luiz Vicente Rizzo, Nelson Wolosker
775 [GO] 2020―Sep―17 Brazil's COVID-19 response Denis Souto Valente, Rafaela Koehler Zanella
776 [GO] 2020―Sep―17 Brazil's COVID-19 response Cecilia Siliansky de Andreazzi, Martha Lima Brandão, Marina Galvão Bueno, Gisele R Winck, Fabiana Lopes Rocha, Rafael L G Raimundo, et al. (+4)
777 [GO] 2020―Sep―17 Brazil's COVID-19 response Mauro R N Pontes, Julio Pereira Lima
778 [GO] 2020―Sep―17 COVID-19: a stress test for trust in science The Lancet
779 [GO] 2020―Sep―14 Catalysing the response to NCDI Poverty at a time of COVID-19 Karen Sliwa, Magdi Yacoub
780 [GO] 2020―Sep―14 Lancet COVID-19 Commission Statement on the occasion of the 75th session of the UN General Assembly Jeffrey D Sachs, Salim Abdool Karim, Lara Aknin, Joseph Allen, Kirsten Brosbøl, Gabriela Cuevas Barron, et al. (+29)
781 [GO] 2020―Sep―07 Legal agreements: barriers and enablers to global equitable COVID-19 vaccine access Alexandra L Phelan, Mark Eccleston-Turner, Michelle Rourke, Allan Maleche, Chenguang Wang
782 [GO] 2020―Sep―06 Azithromycin for severe COVID-19 Catherine E Oldenburg, Thuy Doan
783 [GO] 2020―Sep―06 Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial Remo H M Furtado, Otavio Berwanger, Henrique A Fonseca, Thiago D Corrêa, Leonardo R Ferraz, Maura G Lapa, et al. (+27)
784 [GO] 2020―Sep―04 Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia Denis Y Logunov, Inna V Dolzhikova, Olga V Zubkova, Amir I Tukhvatullin, Dmitry V Shcheblyakov, Alina S Dzharullaeva, et al. (+26)
785 [GO] 2020―Sep―04 COVID-19 vaccines: early success and remaining challenges Naor Bar-Zeev, Tom Inglesby
786 [GO] 2020―Sep―03 Is India missing COVID-19 deaths? Patralekha Chatterjee
787 [GO] 2020―Sep―03 COVID-19 exacerbates violence against health workers Sharmila Devi
788 [GO] 2020―Sep―03 Promotion of scientific research on COVID-19 in Turkey Fahrettin Koca
789 [GO] 2020―Sep―03 Italy's first wave of the COVID-19 pandemic has ended: no excess mortality in May, 2020 Gianfranco Alicandro, Giuseppe Remuzzi, Carlo La Vecchia
790 [GO] 2020―Sep―03 COVID-19: a new lens for non-communicable diseases The Lancet
791 [GO] 2020―Aug―29 Testing for responses to the wrong SARS-CoV-2 antigen? Carolina Rosadas, Paul Randell, Maryam Khan, Myra O McClure, Richard S Tedder
792 [GO] 2020―Aug―27 Research and higher education in the time of COVID-19 The Lancet
793 [GO] 2020―Aug―27 Health and medicine cannot solve COVID-19 Amy K McLennan, Anne Katrine Kleberg Hansen, Stanley J Ulijaszek
794 [GO] 2020―Aug―27 Surveillance is underestimating the burden of the COVID-19 pandemic Nisreen A Alwan
795 [GO] 2020―Aug―27 Bangladesh's COVID-19 testing criticised Sophie Cousins
796 [GO] 2020―Aug―27 COVID-19 vaccine trials should seek worthwhile efficacy Philip Krause, Thomas R Fleming, Ira Longini, Ana Maria Henao-Restrepo, Richard Peto, NE Dean, et al. (+14)
797 [GO] 2020―Aug―27 COVID-19 vaccines and neglected pregnancy Pradip Dashraath, Karin Nielsen-Saines, Shabir A Madhi, David Baud
798 [GO] 2020―Aug―20 COVID-19 and readjusting clinical trials Aaron van Dorn
799 [GO] 2020―Aug―20 Pandemics past and dystopian futures Margaret McCartney
800 [GO] 2020―Aug―18 Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study Barnaby E Young, Siew-Wai Fong, Yi-Hao Chan, Tze-Minn Mak, Li Wei Ang, Danielle E Anderson, et al. (+23)
801 [GO] 2020―Aug―17 SARS-CoV-2 renal tropism associates with acute kidney injury Fabian Braun, Marc Lütgehetmann, Susanne Pfefferle, Milagros N Wong, Alexander Carsten, Maja T Lindenmeyer, et al. (+12)
802 [GO] 2020―Aug―13 COVID-19 combination prevention requires attention to structural drivers Kent Buse, Alessandra Nilo, Jules Kim, Mark Heywood, Jeff Acaba
803 [GO] 2020―Aug―13 SARS-CoV-2 PCR testing of skin for COVID-19 diagnostics: a case report Dagmar Jamiolkowski, Beda Mühleisen, Simon Müller, Alexander A Navarini, Alexandar Tzankov, Elisabeth Roider
804 [GO] 2020―Aug―13 Interference in scientific research on COVID-19 in Turkey Hasan Bayram, Nurdan Köktürk, Osman Elbek, Oğuz Kılınç, Abdullah Sayıner, Elif Dağlı
805 [GO] 2020―Aug―13 COVID-19 is an opportunity for reform in dentistry Richard G Watt
806 [GO] 2020―Aug―13 Donation and transplantation activity in the UK during the COVID-19 lockdown Alex R Manara, Lisa Mumford, Chris J Callaghan, Rommel Ravanan, Dale Gardiner
807 [GO] 2020―Aug―13 Sex differential in COVID-19 mortality varies markedly by age Sunil S Bhopal, Raj Bhopal
808 [GO] 2020―Aug―13 COVID-19's impact on Australia's health research workforce Anna Peeters, Greg Mullins, Denise Becker, Liliana Orellana, Patricia Livingston
809 [GO] 2020―Aug―13 COVID-19 trial co-enrolment and subsequent enrolment Elie Gertner
810 [GO] 2020―Aug―13 COVID-19 worsens Zimbabwe's health crisis Munyaradzi Makoni
811 [GO] 2020―Aug―13 Humanitarian crises in a global pandemic The Lancet
812 [GO] 2020―Aug―10 Patient-reported outcomes: central to the management of COVID-19 Olalekan Lee Aiyegbusi, Melanie J Calvert
813 [GO] 2020―Aug―06 Egyptian health workers arrested after COVID-19 comments Sharmila Devi
814 [GO] 2020―Aug―06 The Cummings effect: politics, trust, and behaviours during the COVID-19 pandemic Daisy Fancourt, Andrew Steptoe, Liam Wright
815 [GO] 2020―Aug―06 The need for an independent evaluation of the COVID-19 response in Spain Alberto García-Basteiro, Carlos Alvarez-Dardet, Alex Arenas, Rafael Bengoa, Carme Borrell, Margarita Del Val, et al. (+14)
816 [GO] 2020―Aug―06 COVID-19-a very visible pandemic Evan J Keil
817 [GO] 2020―Aug―06 COVID-19-a very visible pandemic Carina King, Lena Einhorn, Nele Brusselaers, Marcus Carlsson, Stefan Einhorn, Fredrik Elgh, et al. (+15)
818 [GO] 2020―Aug―06 COVID-19-a very visible pandemic Johanna F Lindahl, Björn Olsen, Åke Lundkvist
819 [GO] 2020―Aug―06 COVID-19-a very visible pandemic David N Durrheim, Michael G Baker
820 [GO] 2020―Aug―06 COVID-19-a very visible pandemic Andrew Ewing
821 [GO] 2020―Aug―06 COVID-19-a very visible pandemic Raja Ramachandran
822 [GO] 2020―Aug―06 COVID-19-a very visible pandemic - Author's reply Johan Giesecke
823 [GO] 2020―Aug―06 Seroprevalence and presentation of SARS-CoV-2 in pregnancy Francesca Crovetto, Fàtima Crispi, Elisa Llurba, Francesc Figueras, María Dolores Gómez-Roig, Eduard Gratacós
824 [GO] 2020―Aug―03 COVID-19 spread in the UK: the end of the beginning? Roy M Anderson, T Déirdre Hollingsworth, Rebecca F Baggaley, Rosie Maddren, Carolin Vegvari
825 [GO] 2020―Jul―30 Political and institutional perils of Brazil's COVID-19 crisis Lorena G Barberia, Eduardo J Gómez
826 [GO] 2020―Jul―30 COVID-19 has “devastating” effect on women and girls Sophie Cousins
827 [GO] 2020―Jul―27 Impacts of COVID-19 on childhood malnutrition and nutrition-related mortality Derek Headey, Rebecca Heidkamp, Saskia Osendarp, Marie Ruel, Nick Scott, Robert Black, et al. (+5)
828 [GO] 2020―Jul―27 Child malnutrition and COVID-19: the time to act is now Henrietta H Fore, Qu Dongyu, David M Beasley, Tedros A Ghebreyesus
829 [GO] 2020―Jul―23 Offline: Preparing for a vaccine against COVID-19 Richard Horton
830 [GO] 2020―Jul―23 COVID-19 and China: lessons and the way forward The Lancet
831 [GO] 2020―Jul―23 COVID-19 cases surge in Colombia Joe Parkin Daniels
832 [GO] 2020―Jul―23 Australia's First Nations' response to the COVID-19 pandemic Sandra Eades, Francine Eades, Daniel McCaullay, Lesley Nelson, Péta Phelan, Fiona Stanley
833 [GO] 2020―Jul―23 Dramatic interventions in the tragedy of the COVID-19 pandemic Cynda H Rushton, Bryan Doerries, Jeremy Greene, Gail Geller
834 [GO] 2020―Jul―23 COVID-19 vaccine affordability and accessibility Safura Abdool Karim
835 [GO] 2020―Jul―23 Pandemic science and politics Philip Ball
836 [GO] 2020―Jul―20 Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial Feng-Cai Zhu, Xu-Hua Guan, Yu-Hua Li, Jian-Ying Huang, Tao Jiang, Li-Hua Hou, et al. (+23)
837 [GO] 2020―Jul―20 Encouraging results from phase 1/2 COVID-19 vaccine trials Naor Bar-Zeev, William J Moss
838 [GO] 2020―Jul―20 Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial Pedro M Folegatti, Katie J Ewer, Parvinder K Aley, Brian Angus, Stephan Becker, Sandra Belij-Rammerstorfer, et al. (+353)
839 [GO] 2020―Jul―16 The Lancet-Chatham House Commission on improving population health post COVID-19 Harry Rutter, Richard Horton, Theresa M Marteau
840 [GO] 2020―Jul―16 Offline: COVID-19 and the dangers of Sinophobia Richard Horton
841 [GO] 2020―Jul―16 Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series Benjamin T Bradley, Heather Maioli, Robert Johnston, Irfan Chaudhry, Susan L Fink, Haodong Xu, et al. (+6)
842 [GO] 2020―Jul―16 Strengthening the global effort on COVID-19 research Alice Norton, Jeffrey Mphahlele, Yazdan Yazdanpanah, Peter Piot, Marta Tufet Bayona
843 [GO] 2020―Jul―16 France's COVID-19 response: balancing conflicting public health traditions Laëtitia Atlani-Duault, Franck Chauvin, Yazdan Yazdanpanah, Bruno Lina, Daniel Benamouzig, Lila Bouadma, et al. (+5)
844 [GO] 2020―Jul―16 COVID-19: Africa needs unprecedented attention to strengthen community health systems Lyudmila Nepomnyashchiy, Bernice Dahn, Rachel Saykpah, Mallika Raghavan
845 [GO] 2020―Jul―16 New funds proposed to prevent pandemics Ann Danaiya Usher
846 [GO] 2020―Jul―15 Assessing national performance in response to COVID-19 Dale Fisher, Yik Ying Teo, David Nabarro
847 [GO] 2020―Jul―14 COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England Marion M Mafham, Enti Spata, Raphael Goldacre, Dominic Gair, Paula Curnow, Mark Bray, et al. (+14)
848 [GO] 2020―Jul―10 An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19 Sheila Shaigany, Marlis Gnirke, Allison Guttmann, Hong Chong, Shane Meehan, Vanessa Raabe, et al. (+3)
849 [GO] 2020―Jul―10 Inflammatory olfactory neuropathy in two patients with COVID-19 Daniel Kirschenbaum, Lukas L Imbach, Silvia Ulrich, Elisabeth J Rushing, Emanuela Keller, Regina R Reimann, et al. (+7)
850 [GO] 2020―Jul―10 Community health workers reveal COVID-19 disaster in Brazil Gabriela Lotta, Clare Wenham, João Nunes, Denise Nacif Pimenta
851 [GO] 2020―Jul―09 Retraction and republication: cardiac toxicity of hydroxychloroquine in COVID-19 Christian Funck-Brentano, Lee S Nguyen, Joe-Elie Salem
852 [GO] 2020―Jul―09 The Lancet COVID-19 Commission Jeffrey D Sachs, Richard Horton, Jessamy Bagenal, Yanis Ben Amor, Ozge Karadag Caman, Guillaume Lafortune
853 [GO] 2020―Jul―09 COVID-19: the worst may be yet to come The Lancet
854 [GO] 2020―Jul―09 Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers Catherine F Houlihan, Nina Vora, Thomas Byrne, Dan Lewer, Gavin Kelly, Judith Heaney, et al. (+333)
855 [GO] 2020―Jul―06 SARS-CoV-2 seroprevalence in COVID-19 hotspots Isabella Eckerle, Benjamin Meyer
856 [GO] 2020―Jul―06 Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study Marina Pollán, Beatriz Pérez-Gómez, Roberto Pastor-Barriuso, Jesús Oteo, Miguel A Hernán, Mayte Pérez-Olmeda, et al. (+103)
857 [GO] 2020―Jul―03 Decisive leadership is a necessity in the COVID-19 response Ahmed Mohammed Obaid Al Saidi, Fowsiya Abikar Nur, Ahmed Salim Al-Mandhari, Maha El Rabbat, Assad Hafeez, Abdinasir Abubakar
858 [GO] 2020―Jul―02 After COVID-19, a future for the world's children? Helen Clark, Awa Marie Coll-Seck, Anshu Banerjee, Stefan Peterson, Sarah L Dalglish, Shanthi Ameratunga, et al. (+35)
859 [GO] 2020―Jul―02 Early lessons from a second COVID-19 lockdown in Leicester, UK Joshua Nazareth, Jatinder S Minhas, David R Jenkins, Amandip Sahota, Kamlesh Khunti, Pranab Haldar, Manish Pareek
860 [GO] 2020―Jul―02 The Wakley-Wu Lien Teh Prize Essay 2020: Chinese health workers' experiences during the COVID-19 pandemic Helena Hui Wang, Esther Lau, Richard Horton
861 [GO] 2020―Jul―02 Financial crisis at PAHO in the time of COVID-19: a call for action Arlene King, Jon Kim Andrus, J Peter Figueroa
862 [GO] 2020―Jul―02 Offline: It's time to convene nations to end this pandemic Richard Horton
863 [GO] 2020―Jun―26 The harms of police frisking in times of a pandemic Ghaith Aljayyoussi
864 [GO] 2020―Jun―25 Generation coronavirus? The Lancet
865 [GO] 2020―Jun―25 Myocarditis in a 16-year-old boy positive for SARS-CoV-2 Massimiliano Gnecchi, Francesco Moretti, Emilio Maria Bassi, Sergio Leonardi, Rossana Totaro, Luciano Perotti, et al. (+6)
866 [GO] 2020―Jun―19 Reordering gender systems: can COVID-19 lead to improved gender equality and health? Tania King, Belinda Hewitt, Bradley Crammond, Georgina Sutherland, Humaira Maheen, Anne Kavanagh
867 [GO] 2020―Jun―19 Ethnic disparities in COVID-19 mortality: are comorbidities to blame? Krithi Ravi
868 [GO] 2020―Jun―19 Solidarity in the wake of COVID-19: reimagining the International Health Regulations Allyn L Taylor, Roojin Habibi, Gian Luca Burci, Stephanie Dagron, Mark Eccleston-Turner, Lawrence O Gostin, et al. (+9)
869 [GO] 2020―Jun―18 Challenges for the female academic during the COVID-19 pandemic Brooke Peterson Gabster, Kim van Daalen, Roopa Dhatt, Michele Barry
870 [GO] 2020―Jun―18 Men's health: COVID-19 pandemic highlights need for overdue policy action Peter Baker, Alan White, Rosemary Morgan
871 [GO] 2020―Jun―18 COVID-19 resurgence in Iran Sharmila Devi
872 [GO] 2020―Jun―18 Seeing COVID-19 through José Saramago's Blindness Daniel Marchalik, Dmitriy Petrov
873 [GO] 2020―Jun―18 Global governance for COVID-19 vaccines The Lancet
874 [GO] 2020―Jun―18 Offline: A novel solution to live with coronavirus Richard Horton
875 [GO] 2020―Jun―18 Wakley Prize Essay 2020: medicine and plain truths in a pandemic year Niall Boyce, Bianca Brandon, Gabriella Merry, Joanna Palmer, Jonathan Pimm, Maneet Virdi
876 [GO] 2020―Jun―16 Overcoming fragmentation of health research in Europe: lessons from COVID-19 Karin R Sipido, Fernando Antoñanzas, Julio Celis, Laurent Degos, Richard Frackowiak, Valentin Fuster, et al. (+14)
877 [GO] 2020―Jun―12 COVID-19 and ethnicity: who will research results apply to? Shaun Treweek, Nita G Forouhi, K M Venkat Narayan, Kamlesh Khunti
878 [GO] 2020―Jun―12 COVID-19, nuclear war, and global warming: lessons for our vulnerable world James E Muller, David G Nathan
879 [GO] 2020―Jun―12 Gendered effects of school closures during the COVID-19 pandemic Katarzyna Burzynska, Gabriela Contreras
880 [GO] 2020―Jun―11 Have deaths from COVID-19 in Europe plateaued due to herd immunity? Lucy C Okell, Robert Verity, Oliver J Watson, Swapnil Mishra, Patrick Walker, Charlie Whittaker, et al. (+8)
881 [GO] 2020―Jun―11 COVID-19 vaccines for all? Ann Danaiya Usher
882 [GO] 2020―Jun―11 Offline: COVID-19-what we can expect to come Richard Horton
883 [GO] 2020―Jun―06 Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis Mandeep R Mehra, Frank Ruschitzka, Amit N Patel
884 [GO] 2020―Jun―04 Offline: COVID-19 and the ethics of memory Richard Horton
885 [GO] 2020―Jun―04 Salient lessons from Russia's COVID-19 outbreak The Lancet
886 [GO] 2020―Jun―04 Early evidence of pronounced brain involvement in fatal COVID-19 outcomes Claus Hann von Weyhern, Ines Kaufmann, Frauke Neff, Marcus Kremer
887 [GO] 2020―Jun―04 Active case finding with case management: the key to tackling the COVID-19 pandemic Zhongjie Li, Qiulan Chen, Luzhao Feng, Lance Rodewald, Yinyin Xia, Hailiang Yu, et al. (+53)
888 [GO] 2020―Jun―04 Indigenous populations: left behind in the COVID-19 response Kaitlin Curtice, Esther Choo
889 [GO] 2020―Jun―04 Quantifying additional COVID-19 symptoms will save lives Cristina Menni, Carole H Sudre, Claire J Steves, Sebastien Ourselin, Tim D Spector
890 [GO] 2020―Jun―04 COVID-19 vaccine development pipeline gears up Asher Mullard
891 [GO] 2020―Jun―03 Expression of concern: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis The Lancet Editors
892 [GO] 2020―Jun―01 Physical distancing, face masks, and eye protection for prevention of COVID-19 C Raina MacIntyre, Quanyi Wang
893 [GO] 2020―Jun―01 Informal home care providers: the forgotten health-care workers during the COVID-19 pandemic Emily Ying Yang Chan, Nina Gobat, Jean H Kim, Elizabeth A Newnham, Zhe Huang, Heidi Hung, et al. (+4)
894 [GO] 2020―Jun―01 Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis Derek K Chu, Elie A Akl, Stephanie Duda, Karla Solo, Sally Yaacoub, Holger J Schünemann, et al. (+40)
895 [GO] 2020―May―29 The right to health must guide responses to COVID-19 Dainius Pūras, Judith Bueno de Mesquita, Luisa Cabal, Allan Maleche, Benjamin Mason Meier
896 [GO] 2020―May―29 Mitigating the risks of surgery during the COVID-19 pandemic Paul S Myles, Salome Maswime
897 [GO] 2020―May―29 Cancer and COVID-19: what do we really know? Philip M Poortmans, Valentina Guarneri, Maria-João Cardoso
898 [GO] 2020―May―29 Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study Dmitri Nepogodiev, James C Glasbey, Elizabeth Li, Omar M Omar, Joana FF Simoes, Tom EF Abbott, et al. (+1203)
899 [GO] 2020―May―28 COVID-19 in Africa: no room for complacency The Lancet
900 [GO] 2020―May―28 COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study Lennard Y W Lee, Jean Baptiste Cazier, T Starkey, C D Turnbull, Rachel Kerr, Gary Middleton
901 [GO] 2020―May―28 Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study Nicole M Kuderer, Toni K Choueiri, Dimpy P Shah, Yu Shyr, Samuel M Rubinstein, Donna R Rivera, et al. (+230)
902 [GO] 2020―May―28 Fears of “highly catastrophic” COVID-19 spread in Yemen Sharmila Devi
903 [GO] 2020―May―28 COVID-19 strains remote regions of Peru Barbara Fraser
904 [GO] 2020―May―28 The starting line for COVID-19 vaccine development Nelson Lee, Allison McGeer
905 [GO] 2020―May―28 Offline: After COVID-19-is an “alternate society” possible? Richard Horton
906 [GO] 2020―May―27 A view from UK public health registrars on the challenges of COVID-19 Matilda Allen, Isobel Braithwaite, Shelui Collinson, Youssof Oskrochi, Anamika Basu
907 [GO] 2020―May―27 The COVID-19 MS Coalition-accelerating diagnostics, prognostics, and treatment Weston Struwe, Edward Emmott, Melanie Bailey, Michal Sharon, Andrea Sinz, Fernando J Corrales, et al. (+4)
908 [GO] 2020―May―27 Excess mortality in men and women in Massachusetts during the COVID-19 pandemic Nancy Krieger, Jarvis T Chen, Pamela D Waterman
909 [GO] 2020―May―27 COVID-19 testing delays and pathology services in the UK Jangu Banatvala
910 [GO] 2020―May―25 Assistance Publique-Hôpitaux de Paris' response to the COVID-19 pandemic
911 [GO] 2020―May―25 Caution against corticosteroid-based COVID-19 treatment Chong Tang, Yichuan Wang, Houshan Lv, Zhenpeng Guan, Jin Gu
912 [GO] 2020―May―25 COVID-19-associated hyperviscosity: a link between inflammation and thrombophilia? Cheryl L Maier, Alexander D Truong, Sara C Auld, Derek M Polly, Christin-Lauren Tanksley, Alexander Duncan
913 [GO] 2020―May―25 Revisiting the 1957 and 1968 influenza pandemics Mark Honigsbaum
914 [GO] 2020―May―22 Compassion in a time of COVID-19 Sandro Galea
915 [GO] 2020―May―22 Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial Feng-Cai Zhu, Yu-Hua Li, Xu-Hua Guan, Li-Hua Hou, Wen-Juan Wang, Jing-Xin Li, et al. (+15)
916 [GO] 2020―May―22 Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis Mandeep R Mehra, Sapan S Desai, Frank Ruschitzka, Amit N Patel
917 [GO] 2020―May―22 Chloroquine or hydroxychloroquine for COVID-19: why might they be hazardous? Christian Funck-Brentano, Joe-Elie Salem
918 [GO] 2020―May―21 Offline: Health in the unhappy time of COVID-19 Richard Horton
919 [GO] 2020―May―21 The plight of essential workers during the COVID-19 pandemic The Lancet
920 [GO] 2020―May―21 Detection of SARS-CoV-2 in human breastmilk Rüdiger Groß, Carina Conzelmann, Janis A Müller, Steffen Stenger, Karin Steinhart, Frank Kirchhoff, Jan Münch
921 [GO] 2020―May―20 Attacks against health-care personnel must stop, especially as the world fights COVID-19 Donna McKay, Michele Heisler, Ranit Mishori, Howard Catton, Otmar Kloiber
922 [GO] 2020―May―20 Critically ill patients with COVID-19 in New York City Giacomo Grasselli, Alberto Zanella
923 [GO] 2020―May―20 Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study Matthew J Cummings, Matthew R Baldwin, Darryl Abrams, Samuel D Jacobson, Benjamin J Meyer, Elizabeth M Balough, et al. (+9)
924 [GO] 2020―May―20 Electron microscopy of SARS-CoV-2: a challenging task Cynthia S Goldsmith, Sara E Miller, Roosecelis B Martines, Hannah A Bullock, Sherif R Zaki
925 [GO] 2020―May―20 Electron microscopy of SARS-CoV-2: a challenging task - Authors' reply Zsuzsanna Varga, Andreas J Flammer, Peter Steiger, Martina Haberecker, Rea Andermatt, Annelies Zinkernagel, et al. (+5)
926 [GO] 2020―May―16 Voluntary collective isolation as a best response to COVID-19 for indigenous populations? A case study and protocol from the Bolivian Amazon Hillard S Kaplan, Benjamin C Trumble, Jonathan Stieglitz, Roberta Mendez Mamany, Maguin Gutierrez Cayuba, Leonardina Maito Moye, et al. (+9)
927 [GO] 2020―May―16 Steam inhalation and paediatric burns during the COVID-19 pandemic Colin T Brewster, Jia Choong, Clare Thomas, David Wilson, Naiem Moiemen
928 [GO] 2020―May―16 Sex workers must not be forgotten in the COVID-19 response Lucy Platt, Jocelyn Elmes, Luca Stevenson, Victoria Holt, Stephen Rolles, Rachel Stuart
929 [GO] 2020―May―16 Use of herbal drugs to treat COVID-19 should be with caution Yichang Yang
930 [GO] 2020―May―15 Hypertension, renin-angiotensin-aldosterone system inhibition, and COVID-19 Bryan Williams, Yi Zhang
931 [GO] 2020―May―15 Offline: Don't let COVID-19 divert us completely Richard Horton
932 [GO] 2020―May―15 Emergency ambulance services for heart attack and stroke during UK's COVID-19 lockdown Jenny Lumley Holmes, Simon Brake, Mark Docherty, Richard Lilford, Sam Watson
933 [GO] 2020―May―15 Personal protective equipment needs in the USA during the COVID-19 pandemic Suhas Gondi, Adam L Beckman, Nicholas Deveau, Ali S Raja, Megan L Ranney, Rachel Popkin, Shuhan He
934 [GO] 2020―May―15 Health inequity during the COVID-19 pandemic: a cry for ethical global leadership David Chiriboga, Juan Garay, Paulo Buss, Rocío Sáenz Madrigal, Laetitia Charmaine Rispel
935 [GO] 2020―May―15 Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study Francisco J de Abajo, Sara Rodríguez-Martín, Victoria Lerma, Gina Mejía-Abril, Mónica Aguilar, Amelia García-Luque, et al. (+25)
936 [GO] 2020―May―15 Global coordination on cross-border travel and trade measures crucial to COVID-19 response Kelley Lee, Catherine Z Worsnop, Karen A Grépin, Adam Kamradt-Scott
937 [GO] 2020―May―13 Kawasaki-like disease: emerging complication during the COVID-19 pandemic Russell M Viner, Elizabeth Whittaker
938 [GO] 2020―May―13 Where are the ECDC and the EU-wide responses in the COVID-19 pandemic? Jacint Jordana, Juan Carlos Triviño-Salazar
939 [GO] 2020―May―13 Consider pregnancy in COVID-19 therapeutic drug and vaccine trials Clare L Whitehead, Susan P Walker
940 [GO] 2020―May―13 An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study Lucio Verdoni, Angelo Mazza, Annalisa Gervasoni, Laura Martelli, Maurizio Ruggeri, Matteo Ciuffreda, et al. (+2)
941 [GO] 2020―May―12 Africa faces difficult choices in responding to COVID-19 Titus Divala, Rachael M Burke, Latif Ndeketa, Elizabeth L Corbett, Peter MacPherson
942 [GO] 2020―May―12 Retinal findings in patients with COVID-19 Paula M Marinho, Allexya A A Marcos, André C Romano, Heloisa Nascimento, Rubens Belfort
943 [GO] 2020―May―12 Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study Amitava Banerjee, Laura Pasea, Steve Harris, Arturo Gonzalez-Izquierdo, Ana Torralbo, Laura Shallcross, et al. (+10)
944 [GO] 2020―May―11 Organ procurement and transplantation during the COVID-19 pandemic Alexandre Loupy, Olivier Aubert, Peter P Reese, Olivier Bastien, Florian Bayer, Christian Jacquelinet
945 [GO] 2020―May―10 Interferon beta-1b for COVID-19 Sarah Shalhoub
946 [GO] 2020―May―10 Sharpening the global focus on ethnicity and race in the time of COVID-19 Neeraj Bhala, Gwenetta Curry, Adrian R Martineau, Charles Agyemang, Raj Bhopal
947 [GO] 2020―May―10 Prevention and control of non-communicable diseases in the COVID-19 response Hans Henri P Kluge, Kremlin Wickramasinghe, Holly L Rippin, Romeu Mendes, David H Peters, Anna Kontsevaya, Joao Breda
948 [GO] 2020―May―10 Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial Ivan Fan-Ngai Hung, Kwok-Cheung Lung, Eugene Yuk-Keung Tso, Raymond Liu, Tom Wai-Hin Chung, Man-Yee Chu, et al. (+38)
949 [GO] 2020―May―08 COVID-19: PCR screening of asymptomatic health-care workers at London hospital Thomas A Treibel, Charlotte Manisty, Maudrian Burton, Áine McKnight, Jonathan Lambourne, João B Augusto, et al. (+4)
950 [GO] 2020―May―07 New Zealand eliminates COVID-19 Sophie Cousins
951 [GO] 2020―May―07 Chile plans controversial COVID-19 certificates Barbara Fraser
952 [GO] 2020―May―07 COVID-19 in Brazil: “So what?” The Lancet
953 [GO] 2020―May―07 Calling for a COVID-19 One Health Research Coalition John H Amuasi, Christian Walzer, David Heymann, Hélène Carabin, Le Thi Huong, Andrew Haines, Andrea S Winkler
954 [GO] 2020―May―07 Hyperinflammatory shock in children during COVID-19 pandemic Shelley Riphagen, Xabier Gomez, Carmen Gonzalez-Martinez, Nick Wilkinson, Paraskevi Theocharis
955 [GO] 2020―May―07 Offline: Independent science advice for COVID-19-at last Richard Horton
956 [GO] 2020―May―06 COVID-19-associated nephritis: early warning for disease severity and complications? Oliver Gross, Onnen Moerer, Manfred Weber, Tobias B Huber, Simone Scheithauer
957 [GO] 2020―May―05 Acute limb ischaemia in two young, non-atherosclerotic patients with COVID-19 Paolo Perini, Bilal Nabulsi, Claudio Bianchini Massoni, Matteo Azzarone, Antonio Freyrie
958 [GO] 2020―May―05 Has COVID-19 subverted global health? Richard Cash, Vikram Patel
959 [GO] 2020―May―05 Is the HScore useful in COVID-19? David L Leverenz, Teresa K Tarrant
960 [GO] 2020―May―05 SARS-CoV-2 and influenza virus co-infection Elena Cuadrado-Payán, Enrique Montagud-Marrahi, Manuel Torres-Elorza, Marta Bodro, Miquel Blasco, Esteban Poch, et al. (+2)
961 [GO] 2020―May―05 The invisible pandemic Johan Giesecke
962 [GO] 2020―May―04 Obesity could shift severe COVID-19 disease to younger ages David A Kass, Priya Duggal, Oscar Cingolani
963 [GO] 2020―May―04 COVID-19 immunity passports and vaccination certificates: scientific, equitable, and legal challenges Alexandra L Phelan
964 [GO] 2020―May―04 The COVID-19 response for vulnerable people in places affected by conflict and humanitarian crises David Nott
965 [GO] 2020―May―04 The arrival of SARS-CoV-2 in Venezuela Alberto E Paniz-Mondolfi, Emilia M Sordillo, Marilianna C Márquez-Colmenarez, Lourdes A Delgado-Noguera, Alfonso J Rodriguez-Morales
966 [GO] 2020―May―04 Community participation is crucial in a pandemic Cicely Marston, Alicia Renedo, Sam Miles
967 [GO] 2020―Apr―30 Prisons are “in no way equipped” to deal with COVID-19 Talha Burki
968 [GO] 2020―Apr―30 Considering BCG vaccination to reduce the impact of COVID-19 Nigel Curtis, Annie Sparrow, Tedros A Ghebreyesus, Mihai G Netea
969 [GO] 2020―Apr―30 A COVID-19 conference at AIDS 2020: Virtual Anton Pozniak, Linda-Gail Bekker, Adeeba Kamarulzaman, Monica Gandhi, Richard Horton, Pamela Das, Chris Beyrer
970 [GO] 2020―Apr―30 COVID-19: remaking the social contract The Lancet
971 [GO] 2020―Apr―29 Preventing major outbreaks of COVID-19 in jails Justin T Okano, Sally Blower
972 [GO] 2020―Apr―29 Institutional, not home-based, isolation could contain the COVID-19 outbreak Borame L Dickens, Joel R Koo, Annelies Wilder-Smith, Alex R Cook
973 [GO] 2020―Apr―29 Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial Yeming Wang, Dingyu Zhang, Guanhua Du, Ronghui Du, Jianping Zhao, Yang Jin, et al. (+40)
974 [GO] 2020―Apr―29 Remdesivir for COVID-19: challenges of underpowered studies John David Norrie
975 [GO] 2020―Apr―27 Atypical presentation of COVID-19 in young infants Nadia Nathan, Blandine Prevost, Harriet Corvol
976 [GO] 2020―Apr―27 What policy makers need to know about COVID-19 protective immunity Daniel M Altmann, Daniel C Douek, Rosemary J Boyton
977 [GO] 2020―Apr―27 What does it mean to be made vulnerable in the era of COVID-19? Ayesha Ahmad, Ryoa Chung, Lisa Eckenwiler, Agomani Mitra Ganguli, Matthew Hunt, Rebecca Richards, et al. (+4)
978 [GO] 2020―Apr―23 COVID-19 fault lines Esther K Choo
979 [GO] 2020―Apr―23 India under COVID-19 lockdown The Lancet
980 [GO] 2020―Apr―23 Medical students for health-care staff shortages during the COVID-19 pandemic Sten Rasmussen, Phillip Sperling, Mathias Såby Poulsen, Jeppe Emmersen, Stig Andersen
981 [GO] 2020―Apr―23 Travel restrictions hampering COVID-19 response Sharmila Devi
982 [GO] 2020―Apr―23 Global call to action for inclusion of migrants and refugees in the COVID-19 response Miriam Orcutt, Parth Patel, Rachel Burns, Lucinda Hiam, Rob Aldridge, Delan Devakumar, et al. (+3)
983 [GO] 2020―Apr―23 Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes Denis Doyen, Pamela Moceri, Dorothée Ducreux, Jean Dellamonica
984 [GO] 2020―Apr―22 Neurosurgery in an infant with COVID-19 Giorgio Carrabba, Leonardo Tariciotti, Sophie Guez, Edoardo Calderini, Marco Locatelli
985 [GO] 2020―Apr―22 First experience of COVID-19 screening of health-care workers in England Ewan Hunter, David A Price, Elizabeth Murphy, Ina Schim van der Loeff, Kenneth F Baker, Dennis Lendrem, et al. (+6)
986 [GO] 2020―Apr―22 The key role of palliative care in response to the COVID-19 tsunami of suffering Lukas Radbruch, Felicia Marie Knaul, Liliana de Lima, Cornelis de Joncheere, Afsan Bhadelia
987 [GO] 2020―Apr―22 COVID-19: a need for real-time monitoring of weekly excess deaths David A Leon, Vladimir M Shkolnikov, Liam Smeeth, Per Magnus, Markéta Pechholdová, Christopher I Jarvis
988 [GO] 2020―Apr―21 Endothelial cell infection and endotheliitis in COVID-19 Zsuzsanna Varga, Andreas J Flammer, Peter Steiger, Martina Haberecker, Rea Andermatt, Annelies S Zinkernagel, et al. (+4)
989 [GO] 2020―Apr―21 Hospital-based use of thromboprophylaxis in patients with COVID-19 Alex C Spyropoulos, Walter Ageno, Elliot S Barnathan
990 [GO] 2020―Apr―21 Universal weekly testing as the UK COVID-19 lockdown exit strategy Julian Peto, Nisreen A Alwan, Keith M Godfrey, Rochelle A Burgess, David J Hunter, Elio Riboli, et al. (+28)
991 [GO] 2020―Apr―21 Ethnicity and COVID-19: an urgent public health research priority Manish Pareek, Mansoor N Bangash, Nilesh Pareek, Daniel Pan, Shirley Sze, Jatinder S Minhas, et al. (+2)
992 [GO] 2020―Apr―17 SARS-CoV-2 and viral sepsis: observations and hypotheses Hui Li, Liang Liu, Dingyu Zhang, Jiuyang Xu, Huaping Dai, Nan Tang, et al. (+2)
993 [GO] 2020―Apr―16 Flooded by the torrent: the COVID-19 drug pipeline Asher Mullard
994 [GO] 2020―Apr―16 COVID-19 exacerbating inequalities in the US Aaron van Dorn, Rebecca E Cooney, Miriam L Sabin
995 [GO] 2020―Apr―16 Sustaining containment of COVID-19 in China The Lancet
996 [GO] 2020―Apr―16 COVID-19 in the USA: a question of time The Lancet
997 [GO] 2020―Apr―16 Wearing face masks in the community during the COVID-19 pandemic: altruism and solidarity Kar Keung Cheng, Tai Hing Lam, Chi Chiu Leung
998 [GO] 2020―Apr―16 Sarah Gilbert: carving a path towards a COVID-19 vaccine Richard Lane
999 [GO] 2020―Apr―16 COVID-19: the case for health-care worker screening to prevent hospital transmission James R M Black, Chris Bailey, Joanna Przewrocka, Krijn K Dijkstra, Charles Swanton
1000 [GO] 2020―Apr―15 SARS-CoV-2 shedding and infectivity Barry Atkinson, Eskild Petersen
1001 [GO] 2020―Apr―15 SARS-CoV-2 shedding and infectivity - Authors' reply Fei Zhou, Guohui Fan, Zhibo Liu, Bin Cao
1002 [GO] 2020―Apr―09 The gendered dimensions of COVID-19 The Lancet
1003 [GO] 2020―Apr―09 Regulators split on antimalarials for COVID-19 Susan Jaffe
1004 [GO] 2020―Apr―09 Virtual health care in the era of COVID-19 Paul Webster
1005 [GO] 2020―Apr―09 Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed Marc Feldmann, Ravinder N Maini, James N Woody, Stephen T Holgate, Gregory Winter, Matthew Rowland, et al. (+2)
1006 [GO] 2020―Apr―09 Palliative care and the COVID-19 pandemic The Lancet
1007 [GO] 2020―Apr―09 Centring sexual and reproductive health and justice in the global COVID-19 response Kelli Stidham Hall, Goleen Samari, Samantha Garbers, Sara E Casey, Dazon Dixon Diallo, Miriam Orcutt, et al. (+3)
1008 [GO] 2020―Apr―09 Offline: COVID-19-bewilderment and candour Richard Horton
1009 [GO] 2020―Apr―08 Beware of the second wave of COVID-19 Shunqing Xu, Yuanyuan Li
1010 [GO] 2020―Apr―08 Localising an asset-based COVID-19 response in Ecuador Irene Torres, Fernando Sacoto
1011 [GO] 2020―Apr―08 First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment Kathy Leung, Joseph T Wu, Di Liu, Gabriel M Leung
1012 [GO] 2020―Apr―04 Urgent dental care for patients during the COVID-19 pandemic Manas Dave, Noha Seoudi, Paul Coulthard
1013 [GO] 2020―Apr―02 Monitoring behavioural insights related to COVID-19 Cornelia Betsch, Lothar H Wieler, Katrine Habersaat
1014 [GO] 2020―Apr―02 Redefining vulnerability in the era of COVID-19 The Lancet
1015 [GO] 2020―Apr―02 Global coalition to accelerate COVID-19 clinical research in resource-limited settings
1016 [GO] 2020―Apr―02 The COVID-19 pandemic in the USA: what might we expect? Gerardo Chowell, Kenji Mizumoto
1017 [GO] 2020―Apr―02 Medical student involvement in the COVID-19 response Daniel M Baker, Sanchita Bhatia, Samuel Brown, William Cambridge, Sivesh K Kamarajah, Kenneth A McLean, et al. (+5)
1018 [GO] 2020―Apr―02 COVID-19 will not leave behind refugees and migrants The Lancet
1019 [GO] 2020―Apr―02 Offline: COVID-19-what countries must do now Richard Horton
1020 [GO] 2020―Apr―02 A planetary health perspective on COVID-19: a call for papers Alastair Brown, Richard Horton
1021 [GO] 2020―Apr―02 Developing antibody tests for SARS-CoV-2 Anna Petherick
1022 [GO] 2020―Apr―01 Essential care of critical illness must not be forgotten in the COVID-19 pandemic Tim Baker, Carl Otto Schell, Dan Brun Petersen, Hendry Sawe, Karima Khalid, Samson Mndolo, et al. (+6)
1023 [GO] 2020―Apr―01 Racism and discrimination in COVID-19 responses Delan Devakumar, Geordan Shannon, Sunil S Bhopal, Ibrahim Abubakar
1024 [GO] 2020―Mar―31 Medicine: before COVID-19, and after Margaret McCartney
1025 [GO] 2020―Mar―31 Refugee and migrant health in the COVID-19 response Hans Henri P Kluge, Zsuzsanna Jakab, Jozef Bartovic, Veronika D'Anna, Santino Severoni
1026 [GO] 2020―Mar―31 Ensuring global access to COVID-19 vaccines Gavin Yamey, Marco Schäferhoff, Richard Hatchett, Muhammad Pate, Feng Zhao, Kaci Kennedy McDade
1027 [GO] 2020―Mar―30 Dementia care during COVID-19 Huali Wang, Tao Li, Paola Barbarino, Serge Gauthier, Henry Brodaty, José Luis Molinuevo, et al. (+6)
1028 [GO] 2020―Mar―27 Tracking COVID-19 responsibly Rania Muhareb, Rita Giacaman
1029 [GO] 2020―Mar―27 A role for CT in COVID-19? What data really tell us so far Michael D Hope, Constantine A Raptis, Amar Shah, Mark M Hammer, Travis S Henry
1030 [GO] 2020―Mar―27 Structural violence in the era of a new pandemic: the case of the Gaza Strip David Mills, Bram Wispelwey, Rania Muhareb, Mads Gilbert
1031 [GO] 2020―Mar―26 A citizen's thoughts about COVID-19 Ronald Chow
1032 [GO] 2020―Mar―26 Venezuelan migrants “struggling to survive” amid COVID-19 Joe Parkin Daniels
1033 [GO] 2020―Mar―26 Offline: COVID-19 and the NHS-“a national scandal” Richard Horton
1034 [GO] 2020―Mar―26 COVID-19 cacophony: is there any orchestra conductor? Antoine Flahault
1035 [GO] 2020―Mar―26 COVID-19 gives the lie to global health expertise Sarah L Dalglish
1036 [GO] 2020―Mar―26 WHO launches crowdfund for COVID-19 response Ann Danaiya Usher
1037 [GO] 2020―Mar―26 COVID-19: learning from experience The Lancet
1038 [GO] 2020―Mar―25 Parenting in a time of COVID-19 Lucie Cluver, Jamie M Lachman, Lorraine Sherr, Inge Wessels, Etienne Krug, Sabine Rakotomalala, et al. (+9)
1039 [GO] 2020―Mar―24 COVID-19 in Europe: the Italian lesson Andrea Saglietto, Fabrizio D’Ascenzo, Giuseppe Biondi Zoccai, Gaetano Maria De Ferrari
1040 [GO] 2020―Mar―24 National UK programme of community health workers for COVID-19 response Andy Haines, Enrique Falceto de Barros, Anita Berlin, David L Heymann, Matthew J Harris
1041 [GO] 2020―Mar―24 Immunosuppression for hyperinflammation in COVID-19: a double-edged sword? Andrew I Ritchie, Aran Singanayagam
1042 [GO] 2020―Mar―20 Mass gathering events and reducing further global spread of COVID-19: a political and public health dilemma Brian McCloskey, Alimuddin Zumla, Giuseppe Ippolito, Lucille Blumberg, Paul Arbon, Anita Cicero, et al. (+3)
1043 [GO] 2020―Mar―19 The global community needs to swiftly ramp up the response to contain COVID-19 Dale Fisher, Annelies Wilder-Smith
1044 [GO] 2020―Mar―19 Offline: COVID-19-a reckoning Richard Horton
1045 [GO] 2020―Mar―19 Canada and COVID-19: learning from SARS Paul Webster
1046 [GO] 2020―Mar―19 COVID-19: protecting health-care workers The Lancet
1047 [GO] 2020―Mar―18 COVID-19 battle during the toughest sanctions against Iran Amirhossein Takian, Azam Raoofi, Sara Kazempour-Ardebili
1048 [GO] 2020―Mar―18 COVID-19 cacophony: is there any orchestra conductor? Antoine Flahault
1049 [GO] 2020―Mar―18 Will COVID-19 generate global preparedness? Kathryn H Jacobsen
1050 [GO] 2020―Mar―18 Health security capacities in the context of COVID-19 outbreak: an analysis of International Health Regulations annual report data from 182 countries Nirmal Kandel, Stella Chungong, Abbas Omaar, Jun Xing
1051 [GO] 2020―Mar―17 Clinical course and mortality risk of severe COVID-19 Paul Weiss, David R Murdoch
1052 [GO] 2020―Mar―17 Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures Rachael Pung, Calvin J Chiew, Barnaby E Young, Sarah Chin, Mark I-C Chen, Hannah E Clapham, et al. (+62)
1053 [GO] 2020―Mar―17 Preparedness is essential for malaria-endemic regions during the COVID-19 pandemic Jigang Wang, Chengchao Xu, Yin Kwan Wong, Yingke He, Ayôla A Adegnika, Peter G Kremsner, et al. (+8)
1054 [GO] 2020―Mar―17 Evidence informing the UK's COVID-19 public health response must be transparent Nisreen A Alwan, Raj Bhopal, Rochelle A Burgess, Tim Colburn, Luis E Cuevas, George Davey Smith, et al. (+23)
1055 [GO] 2020―Mar―17 COVID-19: towards controlling of a pandemic Juliet Bedford, Delia Enria, Johan Giesecke, David L Heymann, Chikwe Ihekweazu, Gary Kobinger, et al. (+7)
1056 [GO] 2020―Mar―16 COVID-19: consider cytokine storm syndromes and immunosuppression Puja Mehta, Daniel F McAuley, Michael Brown, Emilie Sanchez, Rachel S Tattersall, Jessica J Manson
1057 [GO] 2020―Mar―13 Did the hesitancy in declaring COVID-19 a pandemic reflect a need to redefine the term? Manfred S Green
1058 [GO] 2020―Mar―13 COVID-19 and Italy: what next? Andrea Remuzzi, Giuseppe Remuzzi
1059 [GO] 2020―Mar―13 First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA Isaac Ghinai, Tristan D McPherson, Jennifer C Hunter, Hannah L Kirking, Demian Christiansen, Kiran Joshi, et al. (+32)
1060 [GO] 2020―Mar―12 COVID-19: the medium is the message Laurie Garrett
1061 [GO] 2020―Mar―11 Comorbidities and multi-organ injuries in the treatment of COVID-19 Tianbing Wang, Zhe Du, Fengxue Zhu, Zhaolong Cao, Youzhong An, Yan Gao, Baoguo Jiang
1062 [GO] 2020―Mar―11 Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Fei Zhou, Ting Yu, Ronghui Du, Guohui Fan, Ying Liu, Zhibo Liu, et al. (+13)
1063 [GO] 2020―Mar―09 How will country-based mitigation measures influence the course of the COVID-19 epidemic? Roy M Anderson, Hans Heesterbeek, Don Klinkenberg, T Déirdre Hollingsworth
1064 [GO] 2020―Mar―09 Middle East respiratory syndrome Ziad A Memish, Stanley Perlman, Maria D Van Kerkhove, Alimuddin Zumla
1065 [GO] 2020―Mar―06 Are high-performing health systems resilient against the COVID-19 epidemic? Helena Legido-Quigley, Nima Asgari, Yik Ying Teo, Gabriel M Leung, Hitoshi Oshitani, Keiji Fukuda, et al. (+4)
1066 [GO] 2020―Mar―06 COVID-19: the gendered impacts of the outbreak Clare Wenham, Julia Smith, Rosemary Morgan
1067 [GO] 2020―Mar―06 SARS-CoV-2 is an appropriate name for the new coronavirus Yuntao Wu, Wenzhe Ho, Yaowei Huang, Dong-Yan Jin, Shiyue Li, Shan-Lu Liu, et al. (+6)
1068 [GO] 2020―Mar―05 COVID-19: too little, too late? The Lancet
1069 [GO] 2020―Mar―04 Mitigate the effects of home confinement on children during the COVID-19 outbreak Guanghai Wang, Yunting Zhang, Jin Zhao, Jun Zhang, Fan Jiang
1070 [GO] 2020―Mar―04 Has China faced only a herald wave of SARS-CoV-2? Antoine Flahault
1071 [GO] 2020―Mar―03 Mass masking in the COVID-19 epidemic: people need guidance Chi Chiu Leung, Tai Hing Lam, Kar Keung Cheng
1072 [GO] 2020―Mar―02 COVID-19 and the anti-lessons of history Robert Peckham
1073 [GO] 2020―Feb―29 The response of Milan's Emergency Medical System to the COVID-19 outbreak in Italy Stefano Spina, Francesco Marrazzo, Maurizio Migliari, Riccardo Stucchi, Alessandra Sforza, Roberto Fumagalli
1074 [GO] 2020―Feb―27 Lessons for managing high-consequence infections from first COVID-19 cases in the UK Peter Moss, Gavin Barlow, Nicholas Easom, Patrick Lillie, Anda Samson
1075 [GO] 2020―Feb―27 Looming threat of COVID-19 infection in Africa: act collectively, and fast John N Nkengasong, Wessam Mankoula
1076 [GO] 2020―Feb―27 Indian pharma threatened by COVID-19 shutdowns in China Patralekha Chatterjee
1077 [GO] 2020―Feb―27 COVID-19: preparing for superspreader potential among Umrah pilgrims to Saudi Arabia Shahul H Ebrahim, Ziad A Memish
1078 [GO] 2020―Feb―27 Secondary attack rate and superspreading events for SARS-CoV-2 Yang Liu, Rosalind M Eggo, Adam J Kucharski
1079 [GO] 2020―Feb―24 COVID-19 control in China during mass population movements at New Year Simiao Chen, Juntao Yang, Weizhong Yang, Chen Wang, Till Bärnighausen
1080 [GO] 2020―Feb―24 Scientists are sprinting to outpace the novel coronavirus Tedros Adhanom Ghebreyesus, Soumya Swaminathan
1081 [GO] 2020―Feb―21 COVID-19: fighting panic with information The Lancet
1082 [GO] 2020―Feb―20 Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study Marius Gilbert, Giulia Pullano, Francesco Pinotti, Eugenio Valdano, Chiara Poletto, Pierre-Yves Boëlle, et al. (+7)
1083 [GO] 2020―Feb―19 Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19 Charles Calisher, Dennis Carroll, Rita Colwell, Ronald B Corley, Peter Daszak, Christian Drosten, et al. (+21)
1084 [GO] 2020―Feb―19 A distinct name is needed for the new coronavirus Shibo Jiang, Zhengli Shi, Yuelong Shu, Jingdong Song, George F Gao, Wenjie Tan, Deyin Guo
1085 [GO] 2020―Feb―17 Timely research papers about COVID-19 in China Yu-Tao Xiang, Wen Li, Qinge Zhang, Yu Jin, Wen-Wang Rao, Liang-Nan Zeng, et al. (+4)
1086 [GO] 2020―Feb―14 Full spectrum of COVID-19 severity still being depicted Zhou Xu, Shu Li, Shen Tian, Hao Li, Ling-quan Kong
1087 [GO] 2020―Feb―14 Full spectrum of COVID-19 severity still being depicted - Authors' reply Xiaoying Gu, Bin Cao, Jianwei Wang
1088 [GO] 2020―Feb―13 Do not violate the International Health Regulations during the COVID-19 outbreak Roojin Habibi, Gian Luca Burci, Thana C de Campos, Danwood Chirwa, Margherita Cinà, Stéphanie Dagron, et al. (+10)
1089 [GO] 2020―Feb―13 COVID-19: what is next for public health? David L Heymann, Nahoko Shindo
1090 [GO] 2020―Feb―13 Africa prepares for coronavirus Munyaradzi Makoni
1091 [GO] 2020―Feb―13 First imported case of 2019 novel coronavirus in Canada, presenting as mild pneumonia William Kyle Silverstein, Lynfa Stroud, Graham Edward Cleghorn, Jerome Allen Leis
1092 [GO] 2020―Feb―13 Anti-Chinese sentiment during the 2019-nCoV outbreak Roger Yat-Nork Chung, Minnie Ming Li
1093 [GO] 2020―Feb―12 Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records Huijun Chen, Juanjuan Guo, Chen Wang, Fan Luo, Xuechen Yu, Wei Zhang, et al. (+8)
1094 [GO] 2020―Feb―12 What are the risks of COVID-19 infection in pregnant women? Jie Qiao
1095 [GO] 2020―Feb―12 On the use of corticosteroids for 2019-nCoV pneumonia Lianhan Shang, Jianping Zhao, Yi Hu, Ronghui Du, Bin Cao
1096 [GO] 2020―Feb―11 2019-nCoV, fake news, and racism Kazuki Shimizu
1097 [GO] 2020―Feb―11 Early lessons from the frontline of the 2019-nCoV outbreak Hong Zhang
1098 [GO] 2020―Feb―11 Minimise nosocomial spread of 2019-nCoV when treating acute respiratory failure Luca Cabrini, Giovanni Landoni, Alberto Zangrillo
1099 [GO] 2020―Feb―07 2019-nCoV epidemic: address mental health care to empower society Yanping Bao, Yankun Sun, Shiqiu Meng, Jie Shi, Lin Lu
1100 [GO] 2020―Feb―07 Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury Clark D Russell, Jonathan E Millar, J Kenneth Baillie
1101 [GO] 2020―Feb―06 What next for the coronavirus response? John Zarocostas
1102 [GO] 2020―Feb―06 2019-nCoV epidemic: what about pregnancies? Guillaume Favre, Léo Pomar, Didier Musso, David Baud
1103 [GO] 2020―Feb―06 What to do next to control the 2019-nCoV epidemic? Fu-Sheng Wang, Chao Zhang
1104 [GO] 2020―Feb―06 2019-nCoV transmission through the ocular surface must not be ignored Cheng-wei Lu, Xiu-fen Liu, Zhi-fang Jia
1105 [GO] 2020―Feb―06 Offline: 2019-nCoV-“A desperate plea” Richard Horton
1106 [GO] 2020―Feb―05 Reducing mortality from 2019-nCoV: host-directed therapies should be an option Alimuddin Zumla, David S Hui, Esam I Azhar, Ziad A Memish, Markus Maeurer
1107 [GO] 2020―Feb―04 Baricitinib as potential treatment for 2019-nCoV acute respiratory disease Peter Richardson, Ivan Griffin, Catherine Tucker, Dan Smith, Olly Oechsle, Anne Phelan, Justin Stebbing
1108 [GO] 2020―Jan―31 Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study Joseph T Wu, Kathy Leung, Gabriel M Leung
1109 [GO] 2020―Jan―30 Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Nanshan Chen, Min Zhou, Xuan Dong, Jieming Qu, Fengyun Gong, Yang Han, et al. (+8)
1110 [GO] 2020―Jan―30 Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding Roujian Lu, Xiang Zhao, Juan Li, Peihua Niu, Bo Yang, Honglong Wu, et al. (+29)
1111 [GO] 2020―Jan―30 Offline: 2019-nCoV outbreak-early lessons Richard Horton
1112 [GO] 2020―Jan―24 Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Chaolin Huang, Yeming Wang, Xingwang Li, Lili Ren, Jianping Zhao, Yi Hu, et al. (+23)
1113 [GO] 2020―Jan―24 A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster Jasper Fuk-Woo Chan, Shuofeng Yuan, Kin-Hang Kok, Kelvin Kai-Wang To, Hin Chu, Jin Yang, et al. (+15)
1114 [GO] 2020―Jan―24 A novel coronavirus outbreak of global health concern Chen Wang, Peter W Horby, Frederick G Hayden, George F Gao
1115 [GO] 2020―Jan―24 Emerging understandings of 2019-nCoV The Lancet
1116 [GO] 2019―Dec―20 Countering the pandemic of gender-based violence and maltreatment of young people: The Lancet Commission Felicia Marie Knaul, Flavia Bustreo, Richard Horton
 [1] 

1116 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.765 sec